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The cell envelope of bacteria is of pivotal importance for growth and survival, and hence 
it is often the target of antimicrobial compounds. One of the main components involved in 
CESRs are extracytoplasmic function (ECF) σ factors. The genome of B. subtilis encodes for 
seven ECF σ factors, σM, σW, σX, σY, σV, σZ and σYlaC. Several studies have been conducted to 
understand the role that these ECF σ factors play in CESR in B. subtilis, one of the challenges 
found is that they display significant redundancy within their regulons. 
In this study, we have performed an in depth analysis of one of the ECF σ factors of B. 
subtilis, σV, which had been previously uncharacterized. We have described the regulon of σV, 
the role that it plays in lysozyme resistance, and provided evidence for a novel promoter element 
important for σV recognition. Additionally, we have studied the role that σM plays in 
moenomycin resistance, and discovered a previously uncharacterized gene, ypmB, that seems to 
play an important role in cell envelope synthesis. Altogether, this dissertation takes further steps 
into understanding of the role that ECF σ factors play in regulating the stress response triggered 
by cell envelope acting antimicrobials in B. subtilis.  
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Cell envelope structure and synthesis in Bacillus subtilis. 
Bacillus subtilis is the best characterized Firmicute (77), and as such, serves as a model for 
understanding a wide range of physiological, developmental and molecular processes. The cell 
envelope of B. subtilis is composed of a cell membrane surrounded by a thick peptidoglycan 
(PG) layer and associated anionic polymers (30, 76) (Figure 1.1). The cell envelope as a whole 
serves of a barrier to counteract changes in the outside environment, provides shape, and actively 
and selectively allows for the exchange of molecules inside and out of the cell (45, 90). 
Therefore, it is no surprise that the cell envelope is a major target for antibiotics. 
The cell membrane of B. subtilis is complex and composed of a predominantly 
phospholipid bilayer with embedded membrane proteins, lipoproteins, and lipid anchored cell 
wall components. Overall the cell membrane is negatively charged due to the abundance of 
anionic lipids (Phosphatidylglycerol and cardiolipin) which contributes to the ability of cationic 
antimicrobial peptides (CAMPs) to disrupt bacterial membrane function (23, 63). Additionally, 
B. subtilis contains teichoic acids (TA) which are either membrane associated (lipoteichoic acid, 
LTA) or PG-associated (wall teichoic acid, WTA) (Figure 1.1) (11). The composition of these 
anionic polymers varies widely between species and can change significantly in response to 
growth conditions (63).  
PG consists of long glycan strands cross-linked via peptide side chains. The abundant 
crosslinking gives rise to a large macromolecule with a high degree of mechanical strength (30). 
2 
 
 
 
 
 
 
Figure1.1. Bacillus subtilis cell envelope structure. (A) Electron micrograph of a B. subtilis cell. 
Modified from (27). (B) Gram positive cell envelope structure. WTA, Wall Teichoic acid. LTA, 
LipoTeichoic Acid. CAP, Covalently Attached Protein. IMP, Integral Membrane Protein. 
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Hence, the PG layer is the major determinant of bacterial cell shape (45). The glycan strands are 
made up of repeating disaccharide residues of N-acetyl glucosamine (GlcNAc) and N-
acetylmuramic (MurNAc) that are crosslinked by peptide side chains. The glycan chain lengths 
vary between species (95). 
Being the major component of the cell wall and due to its great importance, PG synthesis 
is a highly regulated, complex pathway. The first step is the formation of uridine diphosphate-N-
acetyl-muramic acid from uridine diphosphate -N-acetyl-glucosamine. In a series of steps, a 
pentapeptide is added to the MurNAc molecule (47). In B. subtilis, this pentapeptide is composed 
of L-Ala-D-Glu-mDAP-D-Ala-D-Ala. When the UDP-MurNAc-pentapeptide is covalently 
bonded to the membrane bound undecaprenyl-phosphate, Lipid I is formed. When an additional 
GlcNAc is attached to Lipid I, Lipid II is formed. Lipid II is then translocated to the extra-
cytoplasmic face, where the GlcNAc-MurNAc-pentapeptide is incorporated into the nascent PG 
strand by the action of a transglycosylase (TG). Additionally, the pentapeptide side chain is 
cross-linked by a transpeptidase (TP). Many of the enzymes and intermediate products are 
targets of antibiotics (Figure 1.2). 
As the glycan strands grow and polymerize the cross-linking between adjacent strands 
creates a three dimensional meshwork (6, 30, 64). The rigid sugar chains cross-linked with 
flexible peptide bridges allows for the PG layer to be a strong but also elastic stress bearing 
structure, which permits the constant assembly and disassembly that comes with cellular growth 
and division (47).  
PG synthesis, breakdown and assembly require high level coordination of multi-protein 
complexes (25). Rod-shaped bacteria, like B. subtilis, alternate their machineries between 
division and elongation in a process that is spatially and temporally regulated. Several lines of 
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Figure 1.2. Peptidoglycan synthesis in B. subtilis. Antimicrobials relevant to this study are in 
red, the antibiotics with a —| on the step they inhibit, and lysozyme with an arrow where it 
cleaves the PG. GlcNAc, N-Acetyl-glucosamine. MurNAc, N-Acetyl-muramic acid. UDP, 
Uridine diphosphate. m-DAP, meso-diaminopimelic. TP, transpeptidation. TG, 
transglycosylation. Adapted from (47). 
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evidence suggest that the actin like protein, MreB, plays a central role in this regulation (97). 
Furthermore, the synthesis and maturation of PG in cell elongation is scaffolded on MreB, and 
coupled with the tubulin-like protein FtsZ at mid-cell during division (Figure 1.3). 
In accordance to its important role, MreB and its homologs (Mbl and MreBH) recruit and 
interact, directly or indirectly, with proteins involved in cell shape and division (e.g. RodA, 
MreC, MreD, DivIVA), PG biosynthesis and hydrolysis (e.g. MurF, PBP1, PBP2a, PbpH and 
LytE), TA biosynthesis (e.g. TagU and TagT), and a few uncharacterized proteins (e.g. YpmB 
and YerH) (48). 
MreB has been long thought to form continuous helical filaments along the length of the 
cell which has been evidenced shown in multiple studies using fluorescence microscopy (18, 19, 
24, 26, 46). However, recent advances in microscopy techniques and novel biochemical data 
suggest that MreB might function differently than previously thought (97). It is now believed 
that MreB and a few PG elongation proteins are added in short patches as opposed to long helical 
filaments (83, 87). Additionally, this movement has been shown to be bidirectional and follows 
along after synthesis, rather than guiding and determining PG synthesis, as previously thought 
(34). 
On the other hand, FtsZ polymerizes into an oligomeric structure that forms the initial 
ring at midcell, and recruits over a dozen proteins to form the divisome. This multi-protein 
complex carries out the processes of preseptal elongation, septum formation and cell separation 
(2, 29, 74).  
 
1.2 Cell envelope degrading enzymes and antibiotics. 
The pivotal importance of the cell envelope for bacterial growth and survival makes it a perfect 
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Figure 1.3. Peptidoglycan synthesis complexes during division and elongation in B. subtilis. 
FtsZ (blue) assembly of the divisome machinery at the septal ring (Left). MreB (red) assembly of 
the PG synthesis machinery for lateral wall (Right). Adapted from (20, 22, 25, 32, 97).  
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target for antibiotics and antimicrobial compounds. These compounds can either inactivate a 
biosynthetic enzyme, sequester a substrate, or actively degrade PG (Figure 1.2). There are many 
different compounds that attack the cell envelope, here focus will be given to only those that 
pertain to the later chapters. 
 
1.2.1 Moenomycin 
Moenomycins (MOE) are the only known group of antibiotics that directly inhibit bacterial 
peptidoglycan glycosytransferases (67), and they are produced by at least four different 
streptomycete strains (94). Based on their chemical composition, moenomycins are classified as 
phosphoglycolipids (85, 96). They directly inhibit peptidoglycan glycosyltransferases (PGTs) 
involved in the penultimate step of bacterial cell wall biosynthesis (86) by mimicking their 
substrate, lipid IV (Lipid II with an additional disaccharide) (Figure 1.4). Even though they are 
not used in humans due to their suboptimal pharmacokinetic properties, MOE have been 
successfully commercialized as animal growth promoters under the trademarks Flavomycin and 
Flavophospholipol (a natural mixture of structurally related phosphoglycolipids) (70).  
There have been no reports of animal or human isolates resistant to MOE, although many 
Enterococcus faecium strains are reported to be naturally resistant (1). No significant natural 
cross-resistance has been revealed between MOE and other clinically useful classes of antibiotics 
and no plasmid-borne moenomycin resistance determinants have been detected (70). Even 
though its mode of action is well understood, there are currently no mechanisms to explain 
resistance to MOE.  This is the main focus of chapter 4. 
 
1.2.2 Peptidoglycan hydrolases. 
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Figure 1.4. Moenomycin structure and its interaction with transglycosylase. A) Chemical 
structure of the glycolipid moenomycin (82). B) Crystal structure of moenomycin (yellow 
backbone) bound to the transglycosylase domain (white backbone) of PBP2 of S. aureus (55).  
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Bacterial peptidoglycan hydrolases have a large range of functions. They can be involved 
in growth, cell division, autolysis and even signaling. Furthermore, there are examples of 
hydrolases for every glycosidic bond in peptidoglycan (91). Some of these enzymes act on the 
bond between the glycan strand and the peptides, such as N-Acetylmuramyl-L-alanine amidases 
(44), while others act on the peptide sidechain like carboxy- and endopeptidases (35). There are 
also hydrolases that cleave within the glycan strand (glycosidases), such as N-
acetylglucosaminidases, lysozymes and lytic transglycosylases (44). 
Lysozymes hydrolyze the β-1,4 glycosidic bonds between N-acetylmuramic acid 
(MurNAc) and N-acetylglucosamine (GlucNAc) resulting in a product with the a terminal 
reducing MurNAc residue. In contrast, lytic transglycosylases cleave the glycosidic bond with a 
concominant transglycosylation reaction, resulting in the formation of the 1,6-anhydro ring at the 
MurNAc residue of the product (Figure 1.5) (91). 
Aside from its muramidase activity, lysozyme also shows a cationic antimicrobial peptide 
activity (43), and hence, resistance to lysozyme can be achieved through either modification of 
the substrate (for example, O-acetylation) and/or change the overall net charge of the cell 
envelope (for example, D-alanylation) (51). 
Lysozymes are ubiquitous since they can be produced by a broad range of organisms 
from phages, bacteria and fungi to vertebrates and invertebrates. A few bacterial lysozymes have 
been described, such as Pesticin from Yersinia pestis (92), two autolytic lysozymes from 
Enterococcus faecium (3, 49), cellosyl from Streptomyces coelicolor (73, 89) and the autolysin 
LytC from Streptococcus pneumoniae (33).  
Different soil bacteria that share their niche with B. subtilis are known to produce and 
secrete peptidoglycan hydrolases. The genome of S. coelicolor is predicted to encode for 56 
10 
 
 
 
 
 
 
 
 
 
Figure 1.5. Enzymatic cleavage of peptidoglycan by 1, N-Acetyl-glucosaminidases, 2, 
lysozymes and 3, lytic transglycosylases. R, peptide attached to the lactyl residue of MurNAc 
(91). 
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candidate cell wall hydrolases genes, some of these have been confirmed to be hydrolytic 
enzymes that are able to degrade purified cell walls (38). The predatory M. xanthus also 
produces several hydrolytic enzymes with different activities (81).  
 
1.2.3 Signaling by antimicrobial compounds. 
In addition to inhibiting cell growth and killing of competitors, it is now thought that microbial 
metabolites are involved in cell-signalling within a microbial populations as well as at the 
interspecies level (54, 75). 
Free living soil bacteria such as myxococci, bacilli, and streptomycetes undergo dramatic 
developmental changes in response to environmental stimuli. When these bacteria encounter 
each other, the secondary metabolites released to the environment generate a developmental 
response in the surrounding neighbors (79). For example, sporulation of a lawn of S. coelicolor is 
disrupted by a growing colony of B. subtilis within the lawn (80). Interspecies chemical 
communication is of growing importance and relevance and it will be discussed briefly on 
chapter 2. 
 
1.3 RNA polymerase, sigma factors and ECF sigma factors. 
The action of antimicrobial compounds on the cell wall triggers a specific and highly regulated 
stress response. In Gram positive bacteria, this stress response is mediated by two component 
systems and extracytoplasmic sigma factors (47). Several factors ensure the specificity of this 
response, but for the purpose of this dissertation focus will be given to those at the transcriptional 
level, and more specifically, to those which pertain to ECF σ factors.  
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1.3.1 Transcriptional regulation. 
Gene expression is a highly regulated process. A cell not only needs to express all the necessary 
proteins for housekeeping functions, but it also needs to adapt to different environments and, in 
some cases, differentiate into multiple cell types. Gene expression involves the transcription of 
DNA into RNA and the subsequent translation to protein. Since transcription is the first step in 
gene expression it is, in most cases, regulated at many levels (42). The process of transcription 
consists of initiation, processive elongation and termination (21).  
Transcription initiation, the most heavily regulated stage of the transcription cycle, can be 
subdivided into promoter complex formation, abortive initiation, and promoter escape (7). Each 
step involves sequence specific DNA-protein interactions between the RNA polymerase 
(RNAP), the σ subunit and the promoter DNA. The promoter is defined as the region of DNA 
that interacts directly with RNAP during initiation of transcription. The recognized sequence of 
the promoter varies depending on the holoenzyme (RNAP core + σ). For σ70 class promoters (see 
below), the key recognition elements are usually located at -35 and -10 base pairs upstream of 
the transcription start point (68).  
 
1.3.2 RNAP and σ factors 
Even though core RNAP is competent for transcription, it is not capable of promoter-directed 
transcription initiation (8). For transcription initiation, core RNAP requires the specificity 
determining σ factor. The vast majority of σ factors belong to the σ70 family due to their 
relationship to the principal σ factor of Escherichia coli, σ70 (68). A second family of σ factors, 
the σ54 family, forms a RNAP holoenzyme that recognizes promoters with alternative 
recognition elements and needs additional sources of energy for transcription initiation (9).  On 
13 
 
the basis of gene structure and function, the σ70 family can be divided into different groups (40, 
53).  
Group 1 consists of the essential primary σ factors responsible for the majority of 
transcription of housekeeping genes. Group 2 σ factors are closely related to the primary σ 
factors but are dispensable for bacterial growth. Group 3 σ factors are more distantly related to 
σ70 and usually activate a response to specific signals, such as developmental checkpoints. Group 
4, the largest and most diverse group, contains the ECF subfamily which regulates stress 
responses related to the cell envelope. Finally a proposed Group 5 includes proteins that function 
as σ factors but have not been widely recognized due to their divergent sequence; this group 
includes regulators of toxin production (40). 
Multiple sequence alignments of proteins of the σ70 family reveal four regions of 
evolutionary conservation, termed regions 1 to 4 (σ1 to σ4) (40, 53). Only σ2 and σ4 are well 
conserved in all members of the σ70 family (Figure 1.6). σ2 can be subdivided into four sub-
regions (σ2.2- σ2.4) involved in the binding of σ to the core RNAP, and the recognition and 
melting of the -10 element of the promoter DNA. The crystal structure of σ2 has been solved for 
many σ factors (12, 52, 59) and it shows that σ2 is composed of three α helices. The third helix 
includes conserved residues involved in DNA melting and recognition of the -10 element of the 
promoter. σ4 can be subdivided in two sub-regions (σ4.1- σ4.2) involved in binding to the core 
RNAP, recognizing of -35 element of the promoter, and contacting activators. The crystal 
structure for σ4 has also been solved. σ4 consists of two pairs of α helices where the carboxy- 
terminal pair forms a helix-turn-helix motif that contacts the -35 element of the promoter (12, 
88). The helix formed by σ4.1 and σ4.2 sits in the major groove of the promoter DNA and several 
amino acids directly contact the nucleotides (Figure 1.7 A and B) (50).  
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Figure 1.6. Conserved σ factor regions. Modified from (41, 58, 65)  
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The protein structure of RNAP holoenzyme bound to fork-junction promoter DNA has 
been solved for Thermus aquaticus (Taq) (65, 66). The structure shows that all of the sequence-
specific contacts with the promoter are mediated by the σ subunit (Figure 1.8). This structure 
also shows two important aspects of promoter recognition: 1) there seems to be structural 
plasticity in the holoenzyme that allows repositioning of the β-flap and the bound σ4 with respect 
to the DNA, and 2) the RNAP can bend the intervening DNA to correctly position the -10 and -
35 elements with respect to each other.  
Usually, bacteria contain one σ factor devoted to housekeeping functions and an array of 
alternative σ factors that can vary in number and function. In general, organisms with more 
varied lifestyles have more σ factors. These organisms may encounter many different 
environments and stresses that would require adjustments to their metabolism and physiology. 
Since all of these σ factors compete for RNAP, it is not surprising that this process is tightly 
regulated. The σ factor pool in the cell can be adjusted by 1) synthesizing new σ, 2) activating or 
degrading existing σ, or 3) changing competition parameters for RNAP (36).  
 
1.3.3 ECF σ factors of Bacillus subtilis and their role in cell envelope stress response 
The genome of B. subtilis encodes 7 ECF σ factors: σM, σW, σX, σV, σY, σZ and σylaC (39, 40) 
(Figure 1.9). The target genes (or regulon) for five of these have been identified, however σZ and 
σylaC still remain largely unknown (41). Out of the five better studied, σY is the most elusive: it 
appears to control a small regulon of less than a dozen genes with poorly defined functions (16). 
The other four, σM, σW, σX and σV, all seem to play important roles in setting up a defense 
mechanism against antimicrobial compounds and stresses. σM regulates a large set of genes that 
include essential functions of cell division and envelope synthesis (28). It is induced by 
16 
 
 
 
 
 
Figure 1.7. Structural basis of promoter -35 element recognition by σ4 of σ
E
. A) Correlation of 
σ4 and -35 element sequences for E. coli σ
E
. The top shows the sequence of the proposed -35 
element DNA binding region. The residue positions that are important in -35 element DNA 
recognition in the Ec σE4/-35 element DNA structure are highlighted green. The bottom shows 
the known -35 consensus sequence from σE. The three -35 element regions are highlighted with 
the upstream G region (blue), the middle AAC motif (red), and the downstream T rich region 
(green). Lines connecting the two sections indicate protein residue–DNA base interactions 
important for -35 element recognition in the Ec σE4/DNA structure. B) Stereo view of the Ec 
σE4/-35 element DNA complex. The protein is shown as an α-carbon backbone worm, with σ
E
4.1 
colored yellow and σE4.2 colored light blue. The DNA is color-coded in green (light for non-
template and dark for template). Modified from (50).   
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Figure 1.8. Taq RNAP holoenzyme/fork-junction DNA structure. (A) Overall view of the 
complex. (B) Magnified view showing only a part of the complex (66). 
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Figure 1.9. ECF σ factors operons and regulation in B. subtilis. A) Operon organization.  ECF σ 
factor genes are depicted as black arrows and anti σ genes as grey arrows. Genes that are co-
transcribed with the ECF σ factor operon are shown as white arrows. B) ECF σ factor positive 
autoregulation. ECF σ factor is inactivated and bound to the membrane by the anti-σ factor, until 
a signal triggers its release. The free ECF σ factor can now drive the transcription of other genes, 
often distributed around the chromosome, in response to that signal. Modified from (40).   
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bacitracin, vancomycin and moenomycin, amongst other stresses, and its activation confers 
resistance to both bacitracin and moenomycin. Bacitracin inhibits PG synthesis by binding to 
undecaprenyl pyrophosphate (UPP) and thereby preventing its recycling to the monophosphate 
form (78) (Figure 1.2). σM contributes to bacitracin resistance by upregulating the expression of 
bcrC (15, 61), a UPP phosphatase which competes with bacitracin for the UPP substrate (5). 
Moenomycin inhibits the transglycosylation step in PG synthesis (67). However, the mechanism 
by which σM confers moenomycin resistance is not clear, and is the main focus of chapter 4. 
The σW regulon includes at least 60 genes that inactivate, sequester, or eliminate toxic 
compounds from the cell (39). σW is probably the best studied ECF σ factor of B. subtilis. It is 
induced by several cell wall acting antibiotics including fosfomycin, bacitracin and vancomycin 
(10, 17, 71), detergents (e.g. SDS and Triton-X) (17), and alkali stress (98). Activation of σW in 
turn provides resistance to some of its inducers, such as fosfomycin, by up-regulating the 
expression of fosB, a bacillithiol-S-transferase that inactivates fosfomycin (13, 31). A few other 
mechanisms of resistance provided by σW have been studied, but they are beyond the scope of 
this dissertation. 
The σX regulon includes genes which serve to alter cell surface properties to provide 
protection against antimicrobial peptides (14). Two important operons, dltABCDE and pssA-
ybfM-psd, are under σX regulation. The Dlt proteins incorporate positively charged D-alanine 
into TA (69). PssA and Psd catalyze the synthesis of the neutral cytoplasmic membrane lipid 
phosphatidylethanolamine (62). The incorporation of both positively charged TA and neutral 
lipids reduces the overall negative charge of the membrane providing protection against cationic 
antimicrobial peptides (14).  
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σV is perhaps the most recently studied ECF σ factor of B. subtilis. Originally thought to 
regulate only a small set of genes (99), σV didn’t acquire relevance until studies in E. feacalis 
showed that in this organism, σV contributes to survival following heat, acid and ethanol 
treatment (4); and more recently, lysozyme (51). In B. subtilis σV regulates a set of ~30 genes 
and is highly induced by, and provides resistance to, lysozyme (Chapter 2) (37).  
 
1.4 ECF σ factor regulation 
The operon organization of the ECF σ factors of B. subtilis is variable. In general, the σ factor is 
co-transcribed with its anti-σ factor, which is usually a membrane protein that inactivates σ by 
sequestering it to the cytoplasmic membrane (Figure 1.8). In most cases, the ECF σ factors of B. 
subtilis positively regulate their own expression (40). 
The ECF σ factors of B. subtilis recognize structurally similar promoter sequences, 
characterized by a highly conserved AAC motif in the -35 region and a CGT motif in the -10 
region (40), which suggests a potential for regulatory overlap (Figure 1.10). It has been shown 
that the autoregulatory promoter sites for the sigW and the sigX genes are specifically recognized 
by their cognate σ factor; however, only one or two base pair changes in the -10 element can 
switch the target promoter from one σ to another (72). Previous studies in our laboratory have 
shown a significant overlap in the regulon of σW, σX, σM, and more recently σV, suggesting an 
overlap in their recognition specificities (37, 60). Due to this overlap, a given phenotype often 
involves several ECF σ factors (15, 56, 57, 60).  
The concept of overlap in regulation between σ factors is not uncommon. In E. coli this 
phenomenon has been studied in some detail, particularly for σ70 and σS. The stress response σS 
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Figure 1.10. Promoter sequence consensus recognized by the ECF σ factors of B. subtilis. 
Alignments were generated using the promoter sequences recognized by each single or multiple 
σ factors and the consensus were created using the Weblogo serves 
(http://weblogo.berkeley.edu/). Adapted from (37, 60) 
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of E. coli recognizes almost identical promoter elements to the housekeeping σ70. However, there 
have been reports of variable cis-acting promoter features and trans-acting protein factors that 
determine whether a promoter is recognized by RNAP containing σS or σ70 (84). A similar 
situation exists for σ32/σ70, suggesting that extensive functional overlap between σ factors is an 
important phenomenon (93). 
There are several promoter structures that confer specificity for σ factor recognition. In 
chapter 3, we provide evidence for a novel one within the spacer region of ECF σ – recognized 
promoters. 
 
1.5 Dissertation summary 
This dissertation is aimed at taking further steps into the understanding of the role that ECF σ 
factors play in regulating the stress response triggered by cell envelope acting antimicrobials. 
The combination of transcriptional, physiological and biochemical approaches served to 
elucidate a few of these issues and to open up new interesting lines of research. 
In chapter 2 a mutant strain lacking all seven ECF σ factors was used to ectopically 
induce the expression of σV to study the transcriptomic response ensued by the activation of this 
ECF σ factor. The regulon of σV revealed abundant overlap with the regulons of σM, σX and σW. 
Two of the operons regulated by σV, dltABCDE and oatA, proved to be indispensable in 
conferring σV-dependent lysozyme resistance in B. subtilis.  
From the studies derived in chapter 2, it was observed that a stretch of Ts in the spacer 
region of the promoters regulated by σMXWV was highly conserved, and virtually absent from 
promoters only regulated by σMXW. In chapter 3 we hypothesized that the stretch of Ts is 
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important for specificity of recognition by ECF σ factors, and show in vivo and in vitro data that 
this is likely the case. 
Finally, chapter 4 aims to elucidate the mechanism by which σM is responsible for 
moenomycin resistance in B. subtilis. We serendipitously came across a protein of previously 
unknown function, YpmB, which seems to have an important role in cell wall synthesis. 
Overall, B. subtilis proves to be once again a great model for studying cell envelope 
stress response. The crucial function of the bacterial cell wall makes it the perfect target for 
antibiotics and PG degrading enzymes. The ECF σ factors of B. subtilis play a crucial role in 
regulating the setup of a defense mechanism in response to such stresses. Hence the study of 
such mechanisms is of pivotal importance in health and industry. 
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CHAPTER 2 
 
BACILLUS SUBTILIS SIGMA “V” CONFERS LYSOZYME RESISTANCE BY 
ACTIVATION OF TWO CELL WALL MODIFICATION PATHWAYS: PEPTIDOGLYCAN 
O-ACETYLATION AND D-ALANYLATION OF TEICHOIC ACIDS 
 
The seven extracytoplasmic function (ECF) sigma (σ) factors of Bacillus subtilis are broadly 
implicated in resistance to antibiotics and other cell envelope stressors mediated, in part, by 
regulation of cell envelope synthesis and modification enzymes. We here define the regulon of 
σV as including at least 20 operons many of which are also regulated by σM, σX, or σW. The σV 
regulon is strongly and specifically induced by lysozyme and this induction is key to the intrinsic 
resistance of B. subtilis to lysozyme. Strains with null mutations in either sigV or in all seven 
ECF σ factor genes (Δ7ECF) have essentially equal increases in sensitivity to lysozyme. 
Induction of σV in the Δ7ECF background restores lysozyme resistance, whereas induction of 
σM, σX or σW does not. Lysozyme resistance results from the ability of σV to activate the 
transcription of two operons: the autoregulated sigV-rsiV-oatA-yrhK operon and dltABCDE. 
Genetic analyses reveal that oatA and dlt are largely redundant with respect to lysozyme 
sensitivity: single mutants are not affected in lysozyme sensitivity whereas a double oatA dltA 
mutant is as sensitive as a sigV null strain. Moreover, the triple sigV oatA dltA mutant is no more 
sensitive than the oatA dltA double mutant, indicating that there are no other σV-dependent genes 
necessary for lysozyme resistance. Thus, σV confers lysozyme resistance by activation of two 
cell wall modification pathways: O-acetylation of peptidoglycan catalyzed by OatA and D-
alanylation of teichoic acids by DltABCDE. 
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Most of the results of this chapter were published in Guariglia-Oropeza V. and Helmann J.D. 
Journal of Bacteriology. 2011. 193(22):6223-32. 
 
2.1 Introduction 
Bacillus subtilis provides an important model system for the investigation of antibiotic resistance 
mechanisms in gram positive bacteria. As a soil-dwelling bacterium, B. subtilis inhabits a highly 
variable and competitive environment and, as a consequence, has evolved an arsenal of 
protective stress responses. Soil bacteria include many of the most prolific producers of 
antibiotics, including members of both the Firmicutes (including Bacillus spp.) and, most 
notably, the Actinobacteria. Antibiotics frequently target the bacterial cell envelope, including 
both the peptidoglycan cell wall and cell membrane. In response to low levels of antibiotics and 
other cell envelope active compounds, B. subtilis induces complex and multifaceted cell 
envelope stress responses (41). 
Regulation of cell envelope stress responses in B. subtilis frequently involves one or more 
of seven extracytoplasmic function (ECF) sigma (σ) factors (σM, σW, σV, σX, σY, σZ, σYlaC). The 
three most active in non-stressed cells, and the best characterized, are σM, σW and σX (36). σM 
regulates a large set of genes that encode essential functions for cell division and envelope 
synthesis, and its expression is induced by cell envelope active antibiotics, acid, heat, ethanol and 
superoxide stresses (27, 40). The σW regulon includes at least 60 genes that inactivate, sequester, 
or eliminate toxic compounds from the cell, and its expression is induced by a variety of cell 
envelope active compounds, detergents, and alkali stress (15, 19, 35, 43, 73). The σX regulon 
includes genes which serve to alter cell surface properties to provide protection against 
antimicrobial peptides (17) and is also induced by antibiotics that inhibit cell wall synthesis (22). 
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The ECF σ factors of B. subtilis, like those of other bacteria, are regulated at multiple 
levels (64). In general, each σ factor is co-transcribed with an adjacent gene encoding an anti-σ 
factor, which is usually a membrane protein that sequesters its cognate σ factor to the 
cytoplasmic membrane (74). In response to an inducing signal, the anti-σ factor is inactivated, 
often by proteolytic degradation (11, 34). The released σ factor then binds core RNA polymerase 
(RNAP) and directs the activation of specific promoter sites. In most, but not all, cases 
expression of ECF σ factors is positively autoregulated. Studies to date in B. subtilis suggest that 
each ECF σ factor (with the exception of σZ) activates its own expression (2), but does not 
activate expression of other ECF σ factors (36). In some cases, expression is also directed by an 
additional σA-dependent promoter. In contrast, in Mycobacterium tuberculosis, activation of one 
ECF σ factor can induce the expression of another, leading to a transcriptional cascade (60). The 
potential for transcriptional cascades, in which activation of an ECF σ factor induces expression 
of another transcription factor (or even another ECF σ factor), complicates efforts to define those 
targets that are transcribed directly as a result of σ factor reprogramming of RNAP. 
Previous studies have revealed significant overlap in the regulons controlled by σM, σW 
and σX and, as a result, the stimulons induced by various cell envelope stresses often overlap 
extensively (41, 50). Deciphering the stimulons induced by cell envelope active compounds is 
complex due to both the induction of multiple stress-responsive regulators by a single stimulus, 
and substantial overlap between the target genes activated by each ECF σ factor. Regulon 
overlap in B. subtilis results largely from the fact that ECF σ factors recognize similar promoter 
sequences that share a highly conserved AAC motif in the -35 region and a CGt motif in the -10 
region, but may differ in other discriminatory positions (36). In some cases, promoters are 
exclusively activated by only one ECF σ, whereas in other cases two or more ECF σ factors can 
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activate a single target promoter (18, 48). As a result of this regulon overlap, some phenotypes 
are only evident when two or more of the ECF σ factors are deleted (47, 49). 
In contrast with σM, σW and σX, the roles of the other four ECF σ factors (σV, σY, σZ and 
σYlaC) are still poorly understood. An initial study of σY showed that this σ factor controls a small 
regulon and likely controls expression of a toxic bacteriocin and its cognate immunity gene (21). 
The regulons and functions of σZ and σylaC have not been well defined. Two previous studies 
have sought to define the set of genes regulated by σV (2, 75). However, the prolonged 
incubation after induction of σV, the potential for cross-regulation as noted above, and the lack of 
a specific natural inducing signal, have prevented clear insights into the unique physiological 
role(s) of σV. 
Here we show that the ECF σ factor σV plays a major role in resistance to lysozyme. The 
σV regulon is strongly and specifically induced by lysozyme and includes ~20 operons. Two of 
the σV -regulated operons are crucial for lysozyme resistance: the dlt operon and oatA which is 
transcribed as part as the sigV operon. We conclude that lysozyme resistance in B. subtilis is 
largely mediated by activation of two cell wall modification pathways: OatA-dependent 
peptidoglycan O-acetylation and D-alanylation of teichoic acids by DltABCDE. 
 
2.2 Materials and methods 
2.2.1. Strain construction and growth conditions.  
All B. subtilis strains were constructed in the 168 background (Table 2.1). Unless otherwise 
stated bacteria were grown in liquid Luria-Bertani (LB) medium at 37°C with vigorous shaking 
or on solid LB medium containing 1.5% Bactoagar (Difco). All cloning was done in E. coli 
DH5α using ampicillin (AMP, 100 μg/ml) for selection. Chromosomal DNA and plasmid DNA  
34 
 
 
 
 
Table 2.1. Strains and plasmids used in this study. 
Strain or plasmid Genotype or description Construction or reference 
B. subtilis   
168 trpC2 Lab strain 
BSU2007 168 ΔsigMWXYVZylaC (1) 
HB-12010 BSU2007 amyE::PxylA-sigV pVG001 → BSU2007 
HB-12020 BSU2007 amyE::PxylA-sigW pVG003 → BSU2007 
HB-12035 BSU2007 amyE::PxylA-sigM pVG0013 → BSU2007 
HB-12036 BSU2007 amyE::PxylA-sigX pVG004 → BSU2007 
HB-12027 168 sigV::kan LFH-PCR → 168 
HB-12082 168 amyE::PxylA-sigV pVG001 → 168 
HB-0048 CU1065 dltA::spec (17) 
HB-12093 168 dltA::spec HB-0048 ChrDNA → 168 
HB-12083 168 oatA::tet LFH-PCR → 168 
HB-12092 168 oatA::tet dltA::spec HB-12083 ChrDNA → HB-12093 
HB-12129 168 sigV::kan oatA::tet dltA::spec HB-12027 ChrDNA → HB-12092 
HB-10016 168 sigM::tet (48) 
HB-10102 168 sigW::mls (48) 
HB-10103 168 sigX::kan (48) 
Plasmids   
pVG-001 pSWEET-PxylA-sigV (cm
R
) This work 
pVG-003 pSWEET-PxylA-sigW (cm
R
) This work 
pVG-004 pSWEET-PxylA-sigX (cm
R
) This work 
pVG-0013 pSWEET-PxylA-sigM (cm
R
) This work 
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transformations were performed as previously reported (32). The following antibiotics were used 
for selection at their respective concentrations: spectinomycin (SPC; 100 μg/mL) and macrolide-
lincosoamide-streptogramin B (MLS; contains 1 μg/ml erythromycin and 25 μg/ml lincomycin). 
2.2.2. Inducible expression of ECF σ factors in B. subtilis.  
The pSWEET plasmid, which integrates into the amyE locus, was used to construct xylose-
dependent expression strains (10). sigV, sigM, sigW and sigX were amplified from 168 
chromosomal DNA using primers 4556/4557, 4970/4590, 4558/4559 and 4560/4561 (Table 
S2.1) respectively and cloned into pSWEET using PacI and BamHI sites to create pVG001, 
pVG003, pVG004 and pVG013, respectively (Table 2.1). Inducible expression from each 
construct was checked using reporter strains. The plasmids were transformed into a B. subtilis 
strain carrying in-frame deletions of all seven ECF σ factor genes (Δ7ECF) (1) with 
chloramphenicol (CAT, 5 μg/ml) selection to create strains HB12010, HB12020, HB12036 and 
HB12035, respectively (Table 2.1). The same strategy was used to integrate an ectopic copy of 
PxylA-sigV into the wild-type strain 168 to generate strain HB12082. 
2.2.3. Generation of mutant strains.  
Long flanking homology PCR (LFH-PCR) was used to generate deletion mutations in which the 
designated coding region is largely replaced by an antibiotic cassette as previously described (49, 
72). Strain 168 chromosomal DNA was used for PCR amplification of flanking fragments of 
each gene using primers 5148/5501 and 5502/5151 for sigV and 5156/5157 and 5158/5159 for 
oatA (Table S2.1). 
The PCR products were joined to an antibiotic cassette using joining PCR with outside 
primers. The final LFH product was used to transform 168 with selection for kanamycin (KAN, 
10 μg/ml) for sigV::kan and tetracycline (TET, 5 μg/ml) for oatA::tet.  
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2.2.4. Lysozyme sensitivity measurements.  
Lysozyme sensitivity was determined using a disk diffusion assay performed as described 
previously (7, 49). Briefly, the wild-type strain 168 and various mutant strains were grown to 
mid-logarithmic phase (OD600 of 0.4) in LB medium at 37°C with aeration. A 100-μl aliquot of 
these cultures was mixed with 4 ml of 0.75% Müller-Hinton (MH) soft agar (kept at 50°C) and 
directly poured onto MH plates (containing 15 ml of 1.5% MH agar). The plates were then dried 
for 20 min in a laminar airflow hood. Filter paper disks containing 5 μl of 100 mg/ml lysozyme 
were then placed on the top of the agar, and the plates were incubated at 37°C overnight. The 
diameters of the inhibition zones (clear zones) were measured. 
 
2.2.5. RNA extraction for transcriptome analyses.  
A culture of HB12010 (Δ7ECF PxylA-sigV) was grown in LB at 37°C with shaking to an OD600 
of 0.4 then incubated for 20 minutes either with or without 2% xylose. A culture of 168 was 
grown similarly and treated either with or without 0.5 μg/ml lysozyme. Total RNA was isolated 
from three different biological replicates for each experiment with the RNeasy minikit following 
the manufacturer’s instructions (Qiagen Sciences, MD). After DNase treatment with Turbo 
DNA-free (Ambion), RNA concentrations were quantified using a NanoDrop spectrophotometer 
(NanoDrop Tech. Inc., Wilmington, DE) and kept at -20°C. Microarray analyses. 20 μg of total 
RNA was used to make cDNA using the SuperScriptTM Plus Indirect cDNA Labeling System 
(Invitrogen; L1014-04). cDNA was labeled using Alexa Fluor® labeling and microarray analysis 
were performed as described previously (29). Six microarrays (biological triplicates with a dye-
swap) were analyzed for both the σV regulon and lysozyme stimulon determinations. Images 
were processed and normalized using the GenePix Pro 4.0 software package which produces (red 
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and green [R and G]) fluorescence intensity pairs for each gene. Each expression value is 
represented by up to 12 separate measurements (duplicate spots on each of six arrays). Mean 
values and standard deviations were calculated with MS Excel. The normalized microarray 
datasets were filtered to remove those genes that were not expressed at levels significantly above 
background in either condition (sum of mean fluorescence intensity <20). In addition, the mean 
and standard deviation of the fluorescence intensities were computed for each gene, and those for 
which the standard deviation was greater than the mean value were ignored. The fold induction 
values were calculated using the average signal intensities from the three arrays in the different 
conditions. The microarray datasets are available in the NCBI GEO database under accession 
number GSE31563. 
 
2.2.6. Quantitative RT-PCR.  
For quantitative real time PCR (qRT-PCR) specific primers were designed using the B. subtilis 
genome sequence to amplify 100 bp products (Table S2.1). 2 μg of total RNA (isolated as 
described above for transcriptome analysis) was used to make cDNA using TaqMan® Reverse 
transcription reagents following the manufacturer's instructions (Applied Biosystems). The 
cDNA was used for qRT-PCR using iQTM SYBR® Green Supermix in an Applied Biosystems 
7300 Real Time PCR System. Quantification of 23S RNA levels was used as an internal control. 
The foldchange was calculated using the difference in Ct for both conditions. 
 
2.2.7. Determination of consensus promoter sequences.  
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The promoter consensus sequence alignment was performed using the Weblogo software 
(http://weblogo.berkeley.edu/). The σX regulon (11 promoters), σW regulon (30 promoters) and 
σM regulon (30 promoters) are based on published results (15, 17, 18, 27).  
 
2.2.8 Spot-on-lawn assays. 
Spot-on-lawn assays were performed as described (15). Briefly, lawn cells were grown to an 
OD600 of 0.4 in LB. A 100 ml aliquot of these cultures was mixed with 4 ml of 0.7% MS 
(Mannitol Soya) soft agar (kept at 50°C) and directly poured onto MS plates (containing 15 ml 
of 1.5% MS agar). Plates were dried for 20 min in a laminar flow hood. S. coelicolor M145 was 
grown and kept as spore preparations as previously described (42). 5 µL of the spore preparation 
was spotted on top of the agar. Plates were incubated at 28°C and observed after 2 and 5 days. 
 
2.3. Results and discussion 
2.3.1 Induction of σV in a Δ7ECF strain identifies direct targets of σV RNAP.  
Previous studies have reported that artificial induction of σV induces dozens of genes (2, 75), 
suggesting that this ECF σ factor is likely important under some undefined conditions. However, 
only a small subset of genes were consistently detected in these studies which involved long 
incubations after σV induction (at least 2 hrs). Therefore, we sought to re-investigate the σV 
regulon under conditions that reduce indirect effects and preclude transcriptional cascades due to 
activation of other ECF σ factors. 
To define the σV regulon we induced expression of σV in a strain devoid of all other ECF 
σ factors (Δ7ECF) (1, 47). We used DNA microarray hybridization to monitor transcriptional 
changes 20 min. after induction of σV to selectively detect direct effects and thereby define 
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promoters activated by σV RNAP. Analysis of the resulting transcriptome revealed the up-
regulation of ~30 operons including many known from previous work to be also regulated by σM, 
σW and/or σX (Figure 1A and Tables S2.2 and 2.2). There was also weak up-regulation of some 
members of the σB-dependent general stress response (Table S2.2). These results indicate that σV 
can directly activate numerous promoter sites independent of any influence it may also have on 
the expression of other ECF σ factors. 
The most dramatic effect of inducing σV was the strong up-regulation of the sigV operon 
itself, consistent with prior reports of positive autoregulation (2). The induction of sigV itself is 
not informative, since this gene was induced by xylose. However, we also observed very strong 
induction (>40-fold) of genes downstream of sigV including rsiV (encoding anti-σV), oatA 
(encoding a peptidoglycan O-acetyltransferase; (44)), and yrhK (unknown function). Since the 
strain background used for this study (Δ7ECF) carries an in-frame deletion of sigV this induction 
is likely indicative of the autoregulation that would occur in response to natural inducers. 
Most of the remaining genes that responded strongly to the induction of σV are known 
members of the σM, σW and σX regulons. Since this experiment was done in a background 
carrying in-frame deletions of all three of these ECF σ factors, we conclude that this reflects an 
overlap in the promoter recognition properties of these ECF σ factors rather than a transcriptional 
cascade. The induced operons (Table 2.2) include abh, ywaC, bcrC, dltABCDE, pbpX, and yqjL. 
Abh is a paralog of AbrB and functions as a transition state regulator affecting antibiotic 
synthesis and resistance (23, 48), YwaC is a ppGpp synthase (48), BcrC functions as an 
inducible undecaprenyl-pyrophosphate phosphatase and thereby contributes to bacitracin 
resistance (9, 18), the dlt operon encodes enzymes for teichoic acid D-alanylation (53), PbpX is  
40 
 
 
Figure 2.1. The σV regulon. A) The scatterplot represents the average expression levels of genes 
in induced (+ xylose) versus non-induced (- xylose) cultures of B. subtilis Δ7ECF PxylA-sigV. The 
known regulons of σM, σX or σW (MXW), σB, and the genes belonging to the sigV operon are 
labeled. B) The promoter consensus sequence alignment was performed using the Weblogo 
software (http://weblogo.berkeley.edu/) and represents the promoters that are regulated by σM, σX 
or σW and also regulated by σV (σMXWV; top panel) and those promoters that are regulated by σM, 
σX or σW that are not regulated by σV (σMXW; bottom panel).  
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Table 2.2. The σV regulated genes and their functional role. 
 Foldchange
a
    
Category (operon) 
+/- 
xyl 
+/- 
lys 
Regulator
b
 
Function Reference
c
 
Regulation      
  sigV rsiV 357 73 V ECF σ and anti-σ factor (63) 
  abh 26 2 MXW Transition state regulator (AbrB paralogue) (66) 
  ywaC 8 2 MWX ppGpp synthase (putative) (52) 
Cell division and shape      
mafradCmreBCminCD  3 2 MW Cell division and shape determination (24) 
Cell envelope      
  bcrC 42 4 MX undecaprenyl pyrophosphate phosphatase (9) 
  ddl murF 3 2 MWX Peptidoglycan biosynthesis  
  dltABCDE 14 2 MX D-alanylation of teichoic acids (17) 
  pbpX 21 3 XW penicillin binding protein (17) 
  oatA yrhK 46 63 V oatA: O-acetylation of peptidoglycan; yrhK: unknown (7) 
Detoxification      
  yrhHIJ 26 3 MXW cytochrome P450 regulation (46) 
  yqjL 8 2 MW Hydrolase, paraquat resistance (20) 
Miscellaneous      
  mmgD 5 2 E 2-methylcytrate synthase (14) 
  scoB 3 2 E succinyl CoA:3-oxoacid CoA-transferase (subunitB)  
  spoIIB 2 2  stage II sporulation regulation (55) 
  yutH 2 2  spore coat-associated protein (68) 
Unknown      
  yebC 7 3 M putative integral inner membrane protein  
  yocL 5 2 E hypothetical protein (28) 
  ycgR 3 2 M putative permease  
  ytvB 3 4  putative conserved membrane protein  
  ydgA 2 2 K conserved hypothetical protein (61) 
  yvaFE 2 2  putative transcriptional regulator and metabolite-efflux transporter  
  ytwF 2 2  putative sulfur transferase  
  ycgQ 2 2 M conserved hypothetical protein (27) 
a) Foldchange shown for operons represents the average of the foldchanges of each gene in the operon. 
b) V refers to σV, M refers to σM, X refers to σX,  W refers to σW, E refers to σE and K refers to σK. 
c) For those where the reference is not listed the function annotation is based on GenoList (http://genodb.pasteur.fr/cgi-bin/WebObjects/GenoList)   
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an unknown function low molecular weight penicillin-binding protein, and YqjL contributes to 
resistance to paraquat by an unknown mechanism (20). 
These transcriptional profiling results indicate that σV activates both its own operon and a 
well-defined subset of the σM, σX, and σW regulons. Previously, we demonstrated that a key 
feature distinguishing σX and σW specific promoters is the sequence of the -10 consensus 
element: promoters with the sequence CGTA are generally recognized by σW, those with 
sequence CGAC are recognized by σX, and those with the sequence CGTC may be recognized 
by both (57). To begin to define possible promoter features that account for ability of σV to 
activate its specific subset of target operons, we created a consensus alignment of those 
promoters that belong to the σM, σX or σW regulons that were not activated by induction of σV 
(MXW) and compared this with the consensus of those that were also activated by σV (MXWV). 
Interestingly, the consensus for the σMXWV-regulated genes contains a T-rich -30 to -26 
region that is not conserved in the σMXW-only regulated genes (Figure 2.1B). We are currently 
testing the hypothesis that this spacer region sequence is important for promoter recognition by 
σV (Chapter 3). 
 
2.3.2. σV is specifically induced by lysozyme.  
One of the genes most strongly induced by σV is oatA (formerly yrhL) which is immediately 
downstream of sigV-rsiV. B. subtilis oatA encodes an ortholog of an S. aureus peptidoglycan O-
acetyltransferase and has been shown genetically to affect levels of peptidoglycan O-acetylation 
(44). OatA provides lysozyme resistance in pathogenic Staphylococcus species (5, 7) and 
Lactococcus lactis (70). Furthermore, possible orthologs of σV were found to be induced by 
lysozyme exposure in Enterococcus faecalis (45, 46) and Clostridium difficile (38). Together, 
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these results suggest that B. subtilis sigV, and therefore the σV regulon, might be induced by 
lysozyme and thereby provide lysozyme resistance. 
To test for induction by lysozyme we used reporter strains with lacZ fusions to the autoregulated 
promoters of sigV, sigM, sigW, and sigX. β-galactosidase measurements with and without 
lysozyme treatment show that the sigV promoter is strongly (~90-fold) and specifically induced 
by lysozyme (Figure 2.2 A). To verify and extend these results we performed qRT-PCR with 
RNA isolated from wild-type cells treated with different concentrations of lysozyme (Figure 2.2 
B). As little as .01 μg/ml lysozyme strongly induced sigV activity (~10-fold) and, even at 1 
μg/ml lysozyme, there was little if any observable lysis of cells during the 20 min. of treatment. 
This demonstrates that activation of σV is extremely sensitive to even mild digestion of the cell 
wall and is not correlated with cell lysis. 
 
2.3.3 The lysozyme stress response is dominated by strong activation of the σV regulon.  
We next sought to obtain a global view of the lysozyme stress response by monitoring the 
changes in the transcriptome induced by short treatment (20 min.) with sub-lethal levels of 
lysozyme known to be sufficient for full induction of the σV regulon. This allows us to compare 
the response elicited in wild-type cells upon naturally inducing σV with the more artificial 
situation of ectopically inducing σV in the Δ7ECF background. Remarkably, the lysozyme 
stimulon is dominated by the strong (>50-fold) induction of sigV and the immediately adjacent 
rsiV, oatA, and yrhK genes. Thus, not only does lysozyme selectively activate σV, there are no 
other cell envelope stress systems that appear to respond strongly to this level of lysozyme. 
Altogether, the lysozyme stimulon includes weak induction of as many as 76 operons (Figure 2.3  
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Figure 2.2. σV is strongly and specifically induced by lysozyme. A) β-galactosidase activity of 
PsigV-lacZ, PsigM-lacZ, PsigW-lacZ, and PsigX-lacZ with or without treatment with a sub-inhibitory 
concentration of lysozyme. Experiment was performed in 3 biological replicas and repeated at 
least three times. Bars represent mean values with error bars indicating the standard deviation. 
Student’s t-tests were performed, and a statistically significant difference (P-value < 0.005) 
between the control (- Lys) and lysozyme treated cells (+Lys) is denoted with an asterisk (*). B) 
qRT-PCR of sigV expression under lysozyme induction. The 168 strain was grown to an OD600 
of 0.4 and incubated for 20 min. with the addition of different concentrations of lysozyme. qRT-
PCR was performed with primers specific for sigV and for 23S rRNA as a control. The bars 
show the fold-change of induction after treatment with lysozyme. The results shown are 
representative of experiments performed at least three times.  
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Figure 2.3. The lysozyme stimulon. The scatterplot represents the average expression levels of 
genes in induced (+ lysozyme) versus non-induced (- lysozyme) cultures of B. subtilis 168. 
Genes belonging to the regulons of σM, σX, or σW (MXW), σB, Fur, and AbrB, and the genes 
belonging to the sigV operon are labeled. 
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and Table S2.3), including several members of the Fur regulon (3). Other inducible genes have 
functions in cell wall biosynthesis, cell division, and antibiotic resistance (Tables 2.2 and S2.3). 
Overall, there is very good congruence between the σV regulon and the lysozyme stimulon 
(Table 2.2). 
One notable difference between the σV regulon (Figure 2.1 A) and the lysozyme stimulon 
(Figure 2.3) is that in the former the induction of genes also potentially regulated by other ECF σ 
factors was generally much stronger. This likely reflects the fact that the σV regulon was 
determined in a strain background devoid of other ECF σ factors that might have otherwise 
contributed to the background expression of these genes. In other words, in wild-type cells the 
lysozyme-dependent induction of some genes is superimposed on their basal transcription. Of the 
seven ECF σ factors, at least two (σM and σX ) are found associated with RNAP in non-stressed 
cells (25) and this likely contributes to basal gene expression.  
 
2.3.4 oatA is cotranscribed with sigV and rsiV.  
The transcriptional analyses above revealed a coordinate induction of oatA with the upstream 
sigV and rsiV genes, suggestive of a likely operon structure. However, a 110 bp gap separates 
rsiV from the downstream oatA gene and this region contains a predicted transcription 
terminator. To test the hypothesis that these genes are expressed as a single transcript, we 
performed qRT-PCR of the intergenic junctions between sigV-rsiV, rsiV-oatA, and oatA-yrhK 
(Figure 2.4). We detected an increase in expression of all intergenic junctions correlated with the 
induction of sigV. These results suggest that the predicted terminator is, at best, only partially 
efficient and the downstream genes can be expressed as part of a read-through transcript. 
Furthermore, there is no predicted σV-dependent promoter in the intergenic region between rsiV  
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Figure 2.4. oatA is part of the sigV operon. qRT-PCR of intergenic junctions after induction of 
σV. A) The 168 strain was grown to an OD600 of 0.4 and incubated for 20 min. either with 
(+Lys) or without (-Lys) 0.5 μg/ml of lysozyme. B) The 168 PxylA-sigV strain was grown to an 
OD600 of 0.4 and incubated for min either with (+Xyl) or without (-Xyl) the addition of 2% 
xylose. qRT-PCR was used to quantify the fold-change of each junction region after treatment. 
Results shown are representative of experiments repeated at least three times. 
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and oatA, and lacZ fusions made with different fragments upstream of oatA have no activity even 
when σV is induced (data not shown). Inspection of published tiling array data (59) also supports 
a likely four gene operon extending from sigV to yrhK. We therefore conclude that oatA is co-
transcribed with sigV, rsiV, and yrhK and that the σV-dependent induction of oatA reflects the 
activity of the sigV autoregulatory promoter. 
 
2.3.5. σV plays a central role in lysozyme resistance.  
We assessed the role of σV in lysozyme resistance using a modified disk diffusion protocol (7). A 
sigV null mutant is nearly as sensitive as a strain missing all 7 ECF σ factors, implying that this 
single ECF σ factor is the major lysozyme resistance determinant (Figure 2.5 A). In preliminary 
studies using a strain with the sigV gene disrupted by a co-directional kan cassette, the role of σV 
in lysozyme resistance was partially masked by read-through transcription into oatA (data not 
shown). Therefore, we used an allelic replacement mutation in which the sigV gene was 
disrupted by a divergently oriented antibiotic cassette (Figure 2.5 A). Identical results were also 
seen when an in-frame deletion of sigV (from Δ7ECF) was used instead of an allelic replacement 
mutant (data not shown). σV had no apparent role in resistance to mutanolysin, which is known 
to cleave peptidoglycan irrespective of MurNAc O-acetylation (71), or to several cell wall active 
antibiotics (bacitracin, nisin, moenomycin, D-cycloserine, polymyxin-B, cefuroxime, 
fosfomycin, vancomycin, and ramoplanin) (data not shown). 
In contrast to sigV, single mutations of the most active ECF σ factors (σM, σX and σW) did 
not affect lysozyme sensitivity. Even a triple sigM sigX sigW null mutant (Δ3) had only a modest 
increase in lysozyme sensitivity (Figure 2.5 A). Thus, these σ factors may play a small role in 
lysozyme resistance, but this is negligible in cells expressing σV. We next tested lysozyme  
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Figure 2.5. σV confers resistance to lysozyme through regulation of oatA and the dlt operon. 
Zone of inhibition experiments were used to quantify lysozyme sensitivity in B. subtilis strains. 
Strains were grown to an OD600 of 0.4 and an inoculum of this culture was used to make a lawn 
of cells on 0.75% MH agar. Disks containing lysozyme were placed on top of the lawn and the 
inhibition of growth was measured after incubation at 37°C for 16 h. Each bar represents the 
average zone of inhibition of a least three assays performed with three biological replicas of each 
strain. The zone of inhibition is expressed as the total diameter (± standard error) of the clear 
zone. A. Lysozyme sensitivity of wildtype and ECF σ factor mutants. B. Lysozyme sensitivity in 
wildtype, Δ7ECF, and ECF σ factor-inducible strains. Data shown is for cultures grown in 
inducing conditions (2% xylose). C. Comparison of lysozyme sensitivity in wildtype and oatA 
and dltA mutants. For all three panels, a statistically significant difference (P-value < 0.005) as 
determined by student’s t-tests is denoted as an asterisk (*).  
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resistance in the Δ7ECF strain upon induction of various ECF σ factors (Figure 2.5 B). Only 
induction of σV restored lysozyme resistance whereas induction of σM, σX and σW had little if any 
effect. These results demonstrate that σV is both necessary and sufficient for the induction of 
lysozyme resistance determinants. 
 
2.3.6 Lysozyme resistance is due to σV-dependent activation of OatA and Dlt.  
Since induction of σV can activate the expression of 20 or more operons (Figure 2.1, Table 2.2), 
we next sought to identify which σV-regulated genes are important for lysozyme resistance. We 
focused our attention on two σV-activated functions previously implicated in lysozyme resistance 
in other organisms: oatA and the dlt operon (5, 7, 46). Although single mutations of either oatA 
or dltA did not affect lysozyme sensitivity, a double oatA dltA mutant was fully as sensitive as a 
sigV null mutant (Figure 2.5 C). We therefore suggest that up-regulation of either or both of 
these operons can account for the role of σV in lysozyme resistance. Support for this notion is 
provided by the finding that the mutation of sigV in an oatA dltA double mutant does not further 
increase sensitivity (Figure 2.5 C). 
These results suggest that in B. subtilis lysozyme resistance is provided by σV through the 
up-regulation of oatA and the dlt operon. The regulation of the dlt operon has been studied in 
detail. The dlt operon is potentially activated by σD (54), σX (17) and σM (27). As noted above, 
oatA is cotranscribed with sigV. To corroborate and extend our microarray results, we performed 
qRT-PCR studies in cells where σV was induced either ectopically with xylose or by lysozyme 
treatment (Table 2.3). As expected, lysozyme treatment strongly induced sigV and oatA in the 
wild-type and sigX null mutant cells, but not in the sigV null mutant. Conversely, ectopic 
induction of sigV also strongly induced oatA and dltA expression (Table 2.3). Ectopic induction 
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of sigX induced dltA, consistent with the reported regulation of this operon by σX (17), but did 
not induce oatA.  
As noted above, induction of σX is unable to restore lysozyme resistance to the Δ7ECF 
strain (Figure 2.5 B). However, induction of σX is clearly sufficient for the strong activation of 
the dlt operon (Table 2.3). This suggests that induction of the dlt operon is not sufficient to 
provide lysozyme resistance in a strain lacking the other six ECF σ factors. In apparent contrast 
to this result, OatA and Dlt are redundant in providing lysozyme resistance to wild-type cells 
(only a double oatA dltA mutant was as sensitive to lysozyme as a sigV mutant; Figure 2.5 C). 
Therefore, in an oatA mutant, dlt appears to be the only σV-dependent operon required to provide 
resistance. However, in the Δ7 strain, which is significantly altered in its physiology (47), the 
artificial induction of Dlt (upon activation of σX) is not sufficient for lysozyme resistance. These 
results can be reconciled if other ECF σ factor-dependent genes also make contributions to 
lysozyme resistance, including perhaps pbpX (39). 
 
2.3.6. Diverse mechanisms of lysozyme resistance. 
Lysozyme hydrolyses the β-1,4 glycosidic bond between N-acetylmuramic acid (MurNAc) and 
N-acetylglucosamine (GlucNAc) (71). In addition to its muramidase activity, lysozyme also has 
a cationic antimicrobial peptide activity (37, 51).  
There have been several different mechanisms reported for lysozyme resistance in Gram 
positive bacteria. Most commonly, resistance is achieved by either modification of the 
peptidoglycan substrate by MurNAc O-acetylation (7, 13) or by changes in the overall net charge 
of the cell envelope by D-alanylation (37). In Staphylococcus aureus, OatA-dependent O-
acetylation and D-alanylation of teichoic acids function synergistically to provide full lysozyme  
53 
 
  
 
 
 
 
 
Table 2.3. qRT-PCR quantitation of sigV, oatA, and dltA expression 
 Transcript (fold-induction) 
Strain / condition sigV oatA dltA 
168 +/- lysozyme 50.5 25.7 2.6 
ΔsigV +/- lysozyme n.a. 1.3 2.0 
ΔsigX +/- lysozyme 82.4 19.6 5.8 
Δ7 PxylA-sigV  +/- xylose n.a. 5.6 5.8 
Δ7 PxylA-sigX  +/- xylose 1.0 0.7 37.4 
n.a: not applicable, since these induction values are not 
meaningful since the gene is deleted (row 2) or artificially 
induced from PxylA (row 4).  
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resistance (5). In this organism, the GraRS two component system plays a key role in lysozyme 
resistance by activating expression of the dlt operon (37). Resistance to lysozyme in 
Enterococcus faecalis is provided by both oatA and dltA, and σV plays an additional, undefined 
role: a sigV dltA oatA triple mutant is more sensitive to lysozyme than either a sigV or dltA oatA 
mutant (46). In this organism, the ECF σV factor acts as a general stress response σ (4), and is not 
required for the expression of oatA or dltA (34). Lactococcus lactis also protects its 
peptidoglycan by O-acetylation and, in this case, oatA transcription is regulated by SpxB (70). In 
L. monocytogenes, lysozyme resistance is achieved by both O-acetylation and N-deacetylation 
(58). In B. anthracis, lysozyme resistance is mediated by both O-acetylation, catalyzed by two 
distinct enzymes, and N-de-acetylation (44), but the regulation of these resistance determinants is 
not yet characterized. 
Here we define both the genetic determinants and the regulatory pathways that control 
intrinsic lysozyme resistance in B. subtilis. In comparison to highly lysozyme resistant 
pathogens, such as S. aureus, B. subtilis is relatively sensitive to lysozyme. Nevertheless, this 
organism clearly maintains an inducible resistance system controlled by σV. B. subtilis was 
shown previously to contain a functional OatA homolog: ~35% of MurNAc residues were O-
acetylated in wild-type cells and this was reduced 2.5-fold in an oatA null mutant (44). Based on 
the results here, it seems likely that the level of MurNAc modification increases significantly in 
cells exposed to even low levels of lysozyme, thereby providing an adaptive mechanism for 
lysozyme resistance. B. subtilis also extensively modifies teichoic acids by D-alanylation (53) 
which is mediated by the products of the dlt operon (50). The dlt operon has been shown to be 
regulated by σD (54), σX (17), σM (27) and, as shown here, σV. Our results indicate that in B. 
subtilis, σV is the major ECF σ factor responsible for lysozyme resistance: a sigV mutant is 
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nearly as sensitive as the Δ7ECF mutant (Figure 2.5 A). When induced, σV activates expression 
of both oatA, encoded as part of the autoregulated sigV operon, and the dltA operon (Tables 2.2 
and 2.3). These two cell wall modification pathways provide redundant mechanisms of lysozyme 
resistance, as also noted in S. aureus (37). 
While this work was in preparation, very similar results were obtained by Ellermeier and 
coworkers (39). They also note that sigV is cotranscribed with oatA and that induction of this 
operon by lysozyme contributes to lysozyme resistance. They further show that the dlt operon 
and pbpX also contribute to lysozyme resistance. While the results of these two studies are 
generally in good agreement, we find that a sigV null mutant is nearly as sensitive as the Δ7ECF 
strain whereas Ho et al. report that a sigV null mutation has only a modest effect (2-fold) on 
lysozyme resistance which is greatly enhanced in strains additionally defective in sigX and/or 
sigM. Our results also differ with respect to the importance of the dlt operon for lysozyme 
resistance. Whereas we see no significant effect of a dlt null mutation on lysozyme resistance 
(Figure 2.5 C), Ho et al. report that a dlt null mutation has a greater effect than a sigV null. The 
reasons for these differences are presently unclear. 
Although hen egg white lysozyme is commonly used for testing lysozyme resistance, it is 
a surrogate for the physiological stresses likely to be encountered in the environment. In human 
mucosal secretions, lysozyme can be present at levels of up to 5 mg/ml which thereby provides 
an important component of innate immunity (26). Indeed, peptidoglycan O-acetylation and 
lysozyme resistance correlate with pathogenicity in S. aureus (6), E. faecalis (46), and likely in 
other human pathogens.  
The role of lysozymes and lysozyme resistance mechanisms has not been as well studied 
in soil bacteria. However, soil bacteria are known to produce and in some cases secrete 
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peptidoglycan degrading enzymes. Myxococcus xanthus, which feeds on other soil bacteria, 
secretes several lytic enzymes (8) including at least one with lysozyme-like activity (31). 
Streptomyces coelicolor also secretes several muramidases (30). Bacillus spp. also produce a 
number of autolytic and peptidoglycan degrading enzymes (62). We are currently studying the 
possibility that σV provides resistance to peptidoglycan degrading enzymes produced by other 
soil bacteria. 
 
2.4. Recent findings 
In hopes of continuing these studies, and to test if σV is involved in resistance to PG hydrolases 
from other organisms, we set up a series of interspecies interaction experiments with known PG 
degrading enzymes producers that inhabit the soil. 
The sporulating actinomycete S. coelicolor is known to produce and secrete several PG 
degrading enzymes (30), and its interaction with B. subtilis has been studied (65). In 
collaboration with the Elliot lab (McMaster University), we obtained a wild-type S. coelicolor 
strain as well as several mutants that either lack or over-produce these hydrolases. Compared to 
wild-type, there was no resistance/sensitivity phenotype observed for either a sigV mutant or an 
rsiV mutant. However, the sigV mutant lawn creates a response of increased release of pigment 
by the S. coelicolor strain, whereas in the rsiV mutant, the pigment production seems to be 
abolished in S. coelicolor (Figure 2.6). We believe this pigment to be actinorhodin, the most 
abundant antibiotic produced by S. coelicolor (16), and in fact, overproduction of actinorhodin in 
response to  competition with other soil bacteria has been reported already (56). However, 
whether σV is involved in this process for B. subtilis remains unclear.  
M. xanthus is also known to produce several degrading enzymes (31, 67). In 
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Figure 2.6. Spot on lawn assays depicting the sensitivity of the wildtype, ΔsigV and ΔrsiV B. 
subtilis lawn strains to spots of S. coelicolor spore preparations.  No significant difference in 
inhibition is observed, however, and increased pigment production can be observed for the ΔrsiV 
lawn. 
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collaboration with the Kirby lab (University of Iowa) we obtained a wild-type M. xanthus strain 
to test against B. subtilis. We performed the experiments in a similar way than with S. coelicolor 
but were not able to obtain a phenotype (data not shown). These experiments were challenged by 
the slow growth of M. xanthus and the difficulties to grow these two organisms together. Hence 
we don’t discard the idea that we could have possibly found interactions, were the experiments 
done differently. 
Autolysins are well known cell wall degrading enzymes produced by many species of 
Bacillus, including B. subtilis (62). These autolysins can be purified rapidly using LiCl (12). We 
tested supernatants, LiCl extracts as well as concentrated cultures of different Bacillus spp, but 
unfortunately could not find any phenotype of the sigV mutant or the rsiV mutants when 
compared to wild-type (data not shown). 
Furthermore, there are different groups currently working on σV and its regulation. 
Hastie, et. al. have found that the mechanism for σV activation in B. subtilis is controlled by 
Regulated Intramembrane Proteolysis (RIP) and that it requires the Site-2 protease RasP (33). 
Additionally, Varahan et. al, report that in E. faecalis, Eep, a membrane-bound zinc 
metalloprotease, is involved in induction of σV under lysozyme treatment by affecting the 
stability of RsiV (69).  
It seems unlikely that the σV role in B. subtilis is exclusively to provide lysozyme 
resistance, however more experiments might be needed to test if σV is involved in other 
processes as well. 
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2.6. Supplementary information 
Table S2.1 Primers used in this study. 
Primer Description Sequence 
4556 sigV-fwd CGCTTAATTAAATCCTAGGTAACAGCCTACG 
4557 sigV-rev CGAGGATCCTATATTCTTCTCTTAATTGC 
4558 sigW-fwd CGCTTAATTAACGAAGCTCGTATACATACAG 
4559 sigW-rev CGAGGATCCCACAATTTGTTCAGGACAGC 
4560 sigX-fwd CGCTTAATTAACTTTTCAAGCTATTCATACG 
4561 sigX-rev CGAGGATCCTAAATATCCTGAGGCGAACG 
4970 sigM-fwd CGCTTAATTAACGTGTATAACATAGAGGGGA 
4590 sigM-rev CGAGGATCCGCTTCTCGAGTTCTTCCTCA 
5148 sigV::kan-up-fwd CAGGCGGCAGAACAAGGCGTTATTG 
5501 sigV::kan-UP-rev CGAGCGCCTACGAGGAATTTGTATCGGCCAACCTGTAGAAATCTTG 
5502 sigV::kan-DO-fwd CCTATCACCTCAAATGGTTCGCTGACGCGCCTATACAGAGCATT 
5151 sigV::kan-do-rev CGGTTCTGCATCTTCGTCAGTGAGC 
5050 RT-dltA fwd ATCTCCTATCCTTGTGTACGGCCAC 
5051 RT-dltA rev GCAATTCTGCTCCAGAGCTTTCGAT 
5352 RT-oatA-fwd TGGCTTGGAACGAGGTCTTACGGAA 
5353 RT-oatA-rev TGCTGATGACAGATGTCGTTTTCCA 
4368 RT-23S-fwd AAAGGCACAAGGGAGCTTGACTGCGAGA 
4369 RT-23S-rev ATGAGCCGACATCGAGGTGCCAAACCT 
5193 RT-sigV-rsiV fwd CGAATACCGTCAAAACGCGCCTATA 
5194 RT-sigV-rsiV rev GCTGATGTCGGCCACATAACGATTC 
5195 RT-rsiV-oatA fwd GCGTCATTTCAAACTTGCTCGTGGG 
5196 RT-rsiV-oatA rev GGCCATCAAGTCCAGGAATGTATCG 
5197 RT-oatA-yrhK fwd TTGACTGCTCTTATTGTTCAGGCGA 
5198 RT-oatA-yrhK rev TTTGGATGTCATGTTCTTCATTTCCTTTCA 
5156 oatA::tet-up-fwd ACGAGACGGTCACAGACACGCCAGA 
5157 oatA::tet-up-rev GAGAACAACCTGCACCATTGCAAGATAGGTGATAAGTGATAACTG 
5158 oatA::tet-do-fwd GGGATCAACTTTGGGAGAGAGTTCCCTGATGGTGTTCACTTGGT 
5159 oatA::tet-do-rev CGCGCCGGCCTTATTATTCATATCG 
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Table S2.2. Genes induced ≥3-fold by xylose in strain Δ7 PxylA-sigV. 
Gene Fold-change Regulator Gene Foldchange Regulator 
sigV 708.5 V yvaG 7.3 B 
xylB 623.4 XYL yebC 6.5 M 
xylA 140.7 XYL radC 6.0 M 
xynP 68.8 XYL yrhM 5.7 V 
yrhL 58.6 V mmgE 5.6 
 
xynB 46.0 XYL ydaE 5.6 B 
ywoA 41.6 M, X, W yhxD 5.3 
 
yrhK 35.4 V ydaD 5.2 B 
yrhI 34.0 M,W mmgD 5.1 
 
spo0M 30.9 W bofC 4.7 B 
abh 26.2 M,X maf 4.6 M 
pbpX 21.1 M,X yjgC 4.3 B 
dltC 17.6 M,X yqhA 4.2 B 
yrhJ 16.8 M,W yfhF 3.9 B 
xylR 15.7 XYL cydB 3.7 W 
dltD 15.7 M,X ynaI 3.7 
 
dltB 15.6 M,X yqeZ 3.6 W 
ysnF 14.1 B yfjS 3.4 
 
yjgD 11.9 B paiB 3.4 
 
cydD 11.7 B yjlB 3.3 
 
dltE 10.9 M,X ycdH 3.3 
 
ytbD 8.2 
 
yveL 3.3 
 
ytbE 7.9 B yqfB 3.2 W 
dltA 7.8 M,X yqfA 3.2 W 
ywaC 7.7 M,W mtlD 3.1 
 
yqjL 7.5 M yfkD 3.0 B 
 
V refers to σV, M refers to σM, X refers to σX,  W refers to σW, B refers to σB. XYL refers to xylose metabolism. 
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Table S2.3. Genes induced ≥1.5-fold by lysozyme in strain 168. 
Gene Fold-change Regulator Gene Fold-change Regulator 
yrhM 104.7 V lytE 1.8 
 
yrhL 63.1 V murF 1.8 M 
yrhK 61.6 V yoqL 1.8 
 
sigV 41.3 V mreC 1.8 M 
ytvB 4.0 
 
yxiL 1.7 
 
ywoA 3.6 MX yopO 1.7 
 
ypjC 3.1 
 
yuiI 1.7 Fur 
yrhI 3.1 MX ykuD 1.7 M 
pbpX 2.6 X yvaE 1.7 
 
radC 2.6 M yfnI 1.7 M 
yozO 2.6 W ydgA 1.7 
 
ywcB 2.5 
 
abrB 1.7 
 
yebC 2.5 M minD 1.7 M 
spoIIIAG 2.5 E yxiJ 1.7 
 
maf 2.5 M yxiG 1.7 
 
ycgR 2.4 M ydhN 1.7 
 
dltB 2.4 MX yxjF 1.7 
 
yybK 2.3 
 
yfmG 1.7 
 
ywbN 2.3 Fur yxiF 1.7 
 
dltD 2.3 MX yxzC 1.7 
 
ddl 2.3 M yqfD 1.6 E 
yfiY 2.2 Fur dhbB 1.6 Fur 
yjbC 2.2 W ytvI 1.6 
 
ywbO 2.2 Fur ywbM 1.6 Fur 
ymaG 2.2 
 
deaD 1.6 
 
yjfC 2.2 
 
yhdG 1.6 TnrA/GlnRA 
ywaC 2.1 M minC 1.6 M 
yopM 2.1 
 
yfiM 1.6 
 
mmgD 2.1 
 
ywhH 1.6 
 
dltC 2.0 MX yybI 1.6 
 
yczG 2.0 
 
yxiH 1.6 
 
yxeB 2.0 Fur proJ 1.6 
 
ywtC 2.0 
 
fhuC 1.6 Fur 
spoIIB 2.0 
 
yvaF 1.6 
 
dltE 2.0 MX yxzG 1.6 
 
ykuO 2.0 Fur yqfT 1.6 
 
fhuG 1.9 Fur rocB 1.6 
 
gerAB 1.9   scoB 1.6 
 
yopX 1.9 
 
ylbJ 1.6 E 
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Table S2.3. Continued. 
Gene Fold-change Regulator Gene Fold-change Regulator 
yocL 1.9 
 
yopV 1.6 
 
ywbL 1.9 Fur yoeB 1.6 
 
ytnA 1.9 M braB 1.5 TnrA/GlnRA 
ycgQ 1.9 M ywcA 1.5 
 
dhbE 1.9 Fur yxiI 1.5 
 
dltA 1.9 MX mreB 1.5 M 
wapA 1.9 
 
yclN 1.5 Fur 
mreD 1.9 M yoaG 1.5 W 
ydaH 1.8 M dhbF 1.5 Fur 
yxiM 1.8 
 
yefC 1.5 
 
maeN 1.8 
 
yccC 1.5 TnrA/GlnRA 
yqjL 1.8 M yxdL 1.5 
 
abh 1.8 MXW spoIVCA 1.5 
 
dhbC 1.8 Fur 
   ydeD 1.8 
 
   V refers to σ
V, M refers to σM, X refers to σX,  W refers to σW, E refers to σE. 
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CHAPTER 3 
 
THE -30/-26 STRETCH OF “T”S: A NEW PROMOTER ELEMENT THAT CONFERS 
SPECIFICITY FOR THE EXTRACYTOPLASMIC FUNCTION SIGMA FACTORS OF 
BACILLUS SUBTILIS WITH OVERLAPPING REGULONS 
 
The extracytoplasmic function (ECF) sigma (σ) factors of B. subtilis regulate a number of 
functions important for cell survival under different stresses. Out of the 7 ECF σ factors of B. 
subtilis, three have been studied in quite some detail (σM, σW, σX). More recently, the regulon 
and induction signal of a fourth σ (σV) has been found. Interestingly, these four σ factors show 
overlap in the genes that they regulate which complicates the study of their functions. There have 
been several promoter structures proposed to provide specificity for σ factor recognition; here we 
describe a novel one. In a previous study, we had shown that the promoters that are able to be 
recognized by σMXW and σV have a conserved stretch of Ts right downstream of their -35 
element. We hypothesized that this stretch of Ts could be important for σV recognition, and thus 
serve as a discriminator for the rest of the ECF σ factors of B. subtilis with overlapping regulons. 
Here, we provide in vivo data that shows that this element is, in fact, important for promoter 
recognition by σV, and that disrupting the stretch of Ts has a detrimental effect on transcription 
driven by this on σ factor. Additionally, disrupting the stretch of Ts has a positive effect on 
transcription dependent on σM in three of the four promoters tested, suggesting that this novel 
promoter element could serve as a discriminator between σV and σM in B. subtilis.  
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The majority of this work was performed by Veronica Guariglia-Oropeza, with the 
exception of the PmurG mutagenesis which was performed by Albert Chen as part of his 
undergraduate project.  
 
3.1. Introduction 
Gene expression is a highly regulated process. A cell not only needs to express all the necessary 
proteins for housekeeping functions, but it also needs to adapt to different environments and, in 
some cases, differentiate into multiple cell types. Gene expression involves the transcription of 
DNA into RNA and the subsequent translation to protein. Since transcription is the first step in 
gene expression it is, in most cases, regulated at many levels (19), often involving sequence 
specific DNA-protein interactions between the RNA polymerase (RNAP), the σ subunit and the 
promoter DNA. The recognized sequence of the promoter varies depending on the holoenzyme 
(RNAP core + σ). For σ70 class promoters, the key recognition elements are usually located at -
35 and -10 base pairs upstream of the transcription start point (32). 
σ factors are believed to recognize clearly distinguishable promoter DNA determinants to 
activate a different set of genes, known as their regulons, however, in many cases two or more σ 
factors recognize the same core promoter elements, and the specificity of the response is 
achieved by variable combinations of cis-acting promoter features, and trans-acting protein 
factors (41). 
One of the best studied cases of overlap in σ factor promoter recognition occurs in E. coli 
between the house keeping σ factor, σ70, and the alternative σ factor, σS; both of which recognize 
very similar core promoter elements. Within the promoter, several different specificity elements 
have been described (Figure 3.1). UP elements consists of A+T-rich sequences located upstream   
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Figure 3.1. Promoter elements that provide σ factor specificity. Graphic representation of the different promoter determinants 
involved in specificity that have been described to date. The UP element, -35 and -10 elements, and the extended -10 element are 
depicted as gray boxes. The spacer region and the +1 transcriptional start site are also labeled. The proposed -30/-26 stretch of Ts is 
shown as a striped box.  
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of the -35 element of many promoters (11, 36, 37). In E. coli, a distal UP-element site has been 
shown to be beneficial for σS recognition, whereas a proximal UP-element favors σ70 selectivity. 
Additionally, σS is able to recognize less conserved -35 elements (42), however how σS utilizes 
the -35 element remains unclear. The spacer region has long been proposed to have a role in 
sigma factor specificity (2). It has been shown that σS is able to tolerate sub-optimal spacer 
lengths, whereas σ70 strongly prefers promoters with 17 bp spacing between the -10 and -35 
elements (42). Additionally, it’s been speculated that the spacer can influence the trajectory or 
flexibility of DNA as it enters the RNAP channel and that region 1.1 of σ70 monitors channel 
entry (21). Interestingly, a -13 C directly upstream of the -10 element (within the spacer region) 
has been shown to be a hallmark of σS-dependent promoters and conversely, counter selected in 
σ70-dependent promoters (12, 25, 30, 43). And finally, an A/T rich discriminator region 
downstream of the -10 promoter element is common in σS-dependent promoters, suggesting a 
possible promoter melting defect of this alternative σ factor (25). In fact, promoter melting 
deficiency has been established as a trademark of alternative σ factors, since many have non 
conserved amino acids at the positions implicated in promoter melting, and a balance between 
melting and recognition seems to be important for promoter recognition specificity (24). Most 
likely, a combination of several of these factors ultimately determines the specificity of each 
promoter. 
The genome of B. subtilis encodes 7 ECF σ factors: σM, σW, σX, σV, σY, σZ and σylaC (15, 
16). The regulons for five of these have been identified (Reviewed in (18)). σM regulates a large 
set of genes that include essential functions of cell division and envelope synthesis (9). The σW 
regulon includes at least 60 genes that inactivate, sequester, or eliminate toxic compounds from 
the cell (15). The σX regulon includes genes which serve to alter cell surface properties to 
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provide protection against antimicrobial peptides (5). σV regulates a set of ~30 genes and is 
involved in resistance to lysozyme (13). σY appears to control a small regulon of less than a 
dozen genes with poorly defined functions (8). The regulons and functions of σZ and σylaC have 
not been yet determined. 
Functional redundancy and regulatory overlap among the ECF σ factors of B. subtilis has 
been thoroughly documented (6, 10, 13, 27, 34), and in several cases, the associated phenotypes 
to lacking a σ factor can only be obtained when mutating two or more of them (26, 28). 
Sequence comparisons studies indicate that the promoters recognized by σX and σW share similar 
-35 elements but are distinguished by different base preference at two key positions in the -10 
element (22). A later study showed that changes to the -10 element are sufficient to switch a 
promoter from the σX to the σW regulon and vice versa (35).  
Even though overlap in regulation has been consistently shown among the ECF σ factors 
of B. subtilis, additional promoter specificity determinants have not been reported. Here we 
propose a novel promoter element, the -30/-26 stretch of Ts, within the spacer region (Figure 3.1) 
which is involved in promoter recognition by the most active ECF σ factors of this organism. 
 
3.2. Materials and methods 
3.2.1. Strains and growth conditions.  
All B. subtilis strains were constructed in the 168 background (Table S3.1). Unless otherwise 
stated bacteria were grown in liquid Luria-Bertani (LB) medium at 37°C with vigorous shaking 
or on solid LB medium containing 1.5% Bactoagar (Difco). All cloning was done in E. coli 
DH5α using ampicillin (AMP, 100 μg/ml) for selection. Chromosomal DNA and plasmid DNA 
transformations were performed as previously reported (14). The following antibiotics were used 
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for selection at their respective concentrations: chloramphenicol (CAT, 10 μg/mL), macrolide-
lincosoamide-streptogramin B (MLS; contains 1 μg/ml erythromycin and 25 μg/ml lincomycin), 
and neomycin (NEO; 10 μg/ml). 
 
3.2.2. Promoter site directed mutagenesis 
The stretch of Ts for each promoter was mutated using overlap extension PCR (20). Briefly, for 
each promoter a set of primers were designed, two universal and flanking, and three pairs of 
mutagenic overlapping primers to introduce the TTTTT → AAAAA, TTTTT → TAAAT, or 
TTTTT → TTATT (Table S3.3). Each mutagenic primer is used in pair with a flanking primer to 
generate two fragments that will have overlapping ends. These two fragments are used in a 
second PCR “fusion” reaction using only the flanking primers, and the resulting fusion product is 
amplified by further PCR.   
 
3.2.3. Transcriptional fusions. 
Promoter regions were amplified from B. subtilis chromosomal DNA using a forward primer 
(~100 bp upstream of the -35 consensus) with restriction site HindIII and a reverse primer 
(typically ~50 bp downstream of the start codon) with restriction site BamHI (Table S3.3). The 
resulting fragments were digested with HindIII and BamHI and cloned into pJPM122 (39) and 
verified by DNA sequencing (Table S3.2). Promoter fusions were introduced into the SPβ 
prophage by a double-crossover event, in which each pJPM122 derivative was linearized with 
ScaI and transformed into B. subtilis strain ZB307A with selection for neomycin resistance. The 
SPβ lysates were prepared by heat induction and used to transduce the wild-type 168, the 
Δ7ECF, and the inducible ECF σ factor strains HB12010, HB12020, HB12035 and HB12036.  
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3.2.4 β-galactosidase assays 
Strains carrying promoter–lacZ fusions were grown to an OD600 of 0.4 in LB, induced with the 
addition of 2% xylose, and samples were collected after 20 min incubation. Non induced controls 
were incubated for 20 min without additions. β-Galactosidase assays were performed as 
previously described (29). 
 
3.2.5 Protein purification 
Core RNAP was purified from 50 g cell paste of B. subtilis as previously described (17). Briefly, 
after lysis, RNAP is precipitated using 5% Polymin P fractionation and then eluted from the 
pellet using TGED buffer pH 8 + 1M NH4Cl. From the 1M eluate, proteins were precipitated by 
adding and equal volume of saturated (100%) ammonium sulfate. The pellet was then desalted 
by dialysis on TGED buffer. RNAP was further purified through three FPLC chromatography 
steps: Heparin column, MonoQ column and a final size exclusion step with Superdex-75 column 
(Amersham biosciences). Finally RNAP was dialyzed into storage buffer (TGED, 50% Glycerol, 
100mM NaCl). 
The sigV gene was PCR amplified from B. subtilis chromosomal DNA with primers 
4626/4627 designed to engineer an NdeI site upstream and a BamHI site downstream of the sigV 
gene (Table S3.3). The PCR product was cloned into pET11a (Novagen) via the NdeI and 
BamHI sites to generate pVG010 (Table S3.2). The sequence of sigV in pVG010 was verified by 
DNA sequencing (Cornell DNA sequencing facility). The resultant plasmid was used to 
transform BL21/DE3(pLys) cells to create strain HE-12023 (Table S3.1). Cells were grown to 
mid-logarithmic phase at 37°C in 1 L of LB medium and 100 mg ml-1 of ampicillin. σV 
expression was induced with 1 mM IPTG for 3 h at 37°C. Cells were collected by centrifugation, 
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resuspended in 20 ml of disruption buffer [50 mM Tris-HCl (pH 8.0), 2 mM EDTA, 0.1 mM 
dithiothreitol (DTT), 1 mM b-mercaptoethanol, 233 mM NaCl, 10% (v/v) glycerol] and lysed by 
sonication. The inclusion bodies were recovered by centrifugation and washed twice with 10 ml 
TEDG buffer [10 mM Tris-HCl (pH 8.0), 10 mM EDTA, 0.1 mM DTT, 10% glycerol] 
containing 0.5% (v/v) Triton X-100 and then dissolved in 10 ml of the same buffer plus 1% (v/v) 
Sarkosyl.  
After centrifugation to remove the insoluble fraction, the supernatant was gradually 
diluted to 100 ml with TEDG-0.01% Triton X-100, to allow renaturation. Following 
renaturation, σV was purified through two FPLC chromatography steps, a MonoQ column and a 
Superdex-75 column (Amersham biosciences). Finally the sample was dialysed into TEDG-0.1 
M NaCl-0.01% (v/v) Triton X-100–50% (v/v) glycerol and stored at -80°C. σM was purified in a 
similar fashion using strain HE-4600 and following a previously described protocol (9). 
 
3.2.5 In-vitro transcription 
Run-off in vitro transcription was performed as previously described (35) using the universal 
flanking primers to amplify the PdltA promoter variants to use as templates. Typical transcription 
reaction mixtures (20 µl) contained 0.36 pmol of core RNAP, 4.5 pmol of σ, 4.2 pmol of δ, and 
0.04 pmol of template DNA in transcription buffer (20 mM Tris-HCl [pH 8.0], 10 mM MgCl2, 
50 mM KCl, 0.5 mM DTT, 0.1 mg of bovine serum albumin/ml, 5% [vol/vol] glycerol, and the 
RNase inhibitor RNasin from Promega at 0.8 U/reaction), to which were added nucleoside 
triphosphate mixtures containing 10 nmol of ATP, GTP, and CTP, 1 nmol of UTP, and 0.6 pmol 
of [a-32P]UTP (3,000 Ci/mmol).  
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Core RNAP, σ, and δ were mixed on ice for 15 min to form RNAP holoenzyme before 
the addition of template DNA and incubation at 37°C for 10 min to allow promoter binding. 
Nucleoside triphosphates were added, and transcription was allowed to proceed for 10 min at 
37°C. Reactions were terminated by the addition of 80 µl of stop solution (2.5 M NH4 acetate, 
10 mM EDTA, and 0.1 mg of glycogen/ml), extracted with phenol-chloroform, and precipitated 
with ethanol. The pellets were dissolved in 8 µl of loading buffer (20 mg of xylene cyanol FF/ml, 
20 mg of bromophenol blue/ml, and 60 mg of urea/ml in 13 Tris-borate-EDTA buffer) and 
subjected to 8 M urea–6% polyacrylamide gel electrophoresis. Reaction products were visualized 
by using a Molecular Dynamics PhosphorImager system and ImageQuant software. 
 
3.3. Results and discussion 
Out of the seven ECF σ factors of B. subtilis, σM, σW, σX and σV are the best understood. A 
transcriptional study on the induction of σV in the absence of all of the other ECF σ factors has 
shown that the set of genes regulated by σV predominantly overlaps with the regulons of σM, σW 
and σX. Furthermore, a consensus built with an alignment of the promoters of genes that belong 
to the σM, σX or σW regulons and are also regulated by σV shows a conserved stretch of Ts that is 
absent in a consensus sequence of promoters of the genes that belong to the σM, σX or σW 
regulons but are not regulated by σV (Figure 3.2). To test if this stretch of Ts has a role in σ 
specificity, we undertook a mutational analysis of five different promoters, four of them 
containing the stretch of Ts and regulated by several ECF σ factors, and one which lacks the 
stretch of Ts and is regulated by one σ factor (Table 3.1). 
 
3.3.1 In vivo analysis – Stretch of Ts deleted 
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Figure 3.2. The -30/-26 stretch of Ts is conserved in σV -regulated promoters. The promoter consensus sequence alignments were 
obtained using the Weblogo software (http://weblogo.berkeley.edu/) and represent the promoters that are regulated by σM, σX or σW 
that are not regulated by σV (σMXW; top panel) and those that are regulated by σM, σX or σW and also regulated by σV (σMXWV; bottom 
panel). Promoter sequences were obtained from several studies (4, 5, 7, 9, 13, 23) The highly conserved -28 T is labeled with an 
arrow. Modified from (13). 
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Table 3.1. ECF σ promoters with overlapping regulation. 
Promoter Sequence Regulator 
PdltABCDE aaaaaTGAAACtttttgagc-atctgatCGTCaaataatcA X, M, V 
PbcrC ttattTGAAACttttcatgagtaagattAGTCtactaaAta M, X, V 
PpbpX tttttGACAACttttttagggctttattCGTCtaacaaaac X, M, V 
Pabh aagcgGGAAACtttttcaaagtttcattCGTCtaCGATaTA X, M, W, V 
PmurG ttacgGGAAACccgagagcctctgaagtCGTCtcaataaaGac M 
The region to be mutated is highlighted in gray. Regulator refers to the ECF σ factors of B. 
subtilis in order of their contribution to promoter activity. 
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The four promoters chosen are all regulated by σV as well as by other ECF σ factors (Table 3.1). 
All of these promoters have a stretch of T’s immediately downstream of the -35 element. We 
used overlap extension PCR (20) to mutate the T’s to A’s sequentially (from TTTTT to 
AAAAA, TAAAT, or TTATT). We then cloned the mutated fragments into the vector pJPM122  
to create transcriptional lacZ fusions which were then integrated into the SPβ phage (39). These 
phages were used to transduce the fusions into the desired strains of B. subtilis.  
Our laboratory has developed a set of strains where induction of each ECF σ factor can 
be achieved ectopically and under xylose control in the absence of all other ECF σ factors. (1, 
13). In this way, we can study the activity of the mutated promoters driven by only one σ factor 
at a time, to decipher the contribution of the stretch of Ts, or lack thereof, on transcription 
activity driven from each promoter. We used the SPβ lysates to transduce the wild-type and 
mutant promoter fusions into the inducible strains Δ7sigV, Δ7sigM, Δ7sigW and Δ7sigX. As 
controls, we introduced the promoter variants into the wild-type strain, 168, to assess the normal 
activity of the wild-type promoter and variants in the presence of all ECF σ factors, as well as in 
the Δ7ECF as a negative control. Cells were grown and induced with xylose and β-galactosidase 
activity was measured under inducing and non-inducing conditions using a liquid assay (29). The 
activity driven from each mutated promoter was compared to that of the wild-type promoter. 
The first ECF σ promoter tested was that upstream of dltA, the first gene in the 
dltABCDE operon. This operon codes for the proteins involved in D-alanylation of teichoic 
acids, one cell wall modification pathway that changes the overall net charge (33) and has been 
shown to be involved in resistance to cationic antimicrobial peptides and lysozyme (5, 13). 
Transcription of this promoter is predominantly regulated by σX (5), however activity dependent 
on σM (9) and σV (13) has also been reported.  
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Our results show that even mutating the highly conserved -28 T severely affects the 
activity of this promoter (Figure 3.3). In the wild-type strain 168 (where all ECF σ factors are 
present, albeit most likely at different concentrations), mutating the -28 T (from TTTTT to 
TTATT) decreases the activity of the promoter around 50%. This is also observed for σX and σV. 
Interestingly, the activity of this promoter dependent on only σM is almost doubled, suggesting 
the continuous stretch of five Ts, which is interrupted by mutating the -28 T, could be important 
for sigma factor specificity between σM and σX and σV.  Further mutating the Ts to TAAAT or 
AAAAA reduces the activity dependent on all ECF σ factors tested, suggesting the promoter 
structure has been severely compromised. 
 The next two promoters tested, PbcrC and PpbpX showed a very similar pattern to that of 
PdltA. The bcrC gene (formerly ywoA) encodes for an undecaprenyl pyrophosphate phosphatase 
and has been shown to be important for bacitracin resistance (3). Regulation of this gene is 
primarily dependent on σM, with an additional important role of σX (6). When σM and σX are 
absent, bcrC can also be transcribed via σV (13). Mutating the stretch of Ts in this promoter also 
disrupts its activity (Figure 3.4).  
 Mutating the -28 T decreases the activity of this promoter over 50% in both the wild-type 
background and the σV induced background, showing again the importance of this region. The 
fact that the activity of the wild-type is reduced to 50%, even when activity driven by σM is 
unaffected, suggests that another ECF σ factor (possibly σX) is important under the conditions 
tested. Unfortunately, the data obtained in the inducible σX was inconsistent (data not shown), so 
this hypothesis could not be tested. 
 The gene pbpX encodes for the penicillin-binding endopeptidase X, a low molecular 
weight PBP thought to localize with a FtsZ-like pattern during sporulation (38). Transcription of  
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Figure 3.3. β-galactosidase activity driven from the PdltA promoter and its mutant variants. Data 
corresponds to the induced (+ xylose) β-galactosidase liquid assays. The activity of the wild-type 
(TTTTT) promoter was been set to 100% and the mutant variant activities are expressed as the % 
of wild-type. Experiments were performed at least three times in duplicates; error bars depict the 
standard error.  
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Figure 3.4. β-galactosidase activity driven from the PbcrC promoter and its mutant variants. Data 
corresponds to the induced (+ xylose) β-galactosidase liquid assays. The activity of the wild-type 
(TTTT) promoter was been set to 100% and the mutant variant activities are expressed as the % 
of wild-type. Experiments were performed at least three times in duplicates; error bars depict the 
standard error. 
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pbpX is driven predominantly by σX (5), however activity from σM and σV have also been 
reported (9, 13). Just as for PdltA and PbcrC, mutating the -28 T on the spacer region of the 
promoter affects activity driven by the different ECF σ factors of B. subtilis involved in 
regulation of the transcription of this promoter (Figure 3.5). The activity of this promoter in both 
the wild-type and the σX induced background is reduced 50% on the mutated variant compared to 
the wild-type promoter, going in accordance with σX being the main ECF σ factor responsible for 
transcription of pbpX. Interestingly, mutation of -28 T severely decreases activity driven by σV, 
signifying again the importance of the stretch of Ts in σV specificity. In the same way as with 
PdltA, mutating the -28 T increases activity of PpbpX driven by σ
M
 in added evidence that this novel 
promoter element could be important for distinguishing recognition of ECF σ factors. 
Lastly, we tested the ECF σ promoter upstream of abh. The abh gene encodes for a 
transcriptional regulator paralogous to AbrB, and as such, plays part in the complex 
interconnected system of regulatory functions that controls gene expression during the transition 
from active growth to stationary phase (40). The transcription of abh is predominantly driven by 
σX, a sigX mutant has decreased activity of a Pabh-gfp promoter fusion (31). However, there is 
evidence for the other three most active ECF σ factors of B. subtilis, σW, σM, and σV, to also be 
able to recognize this promoter (9, 13, 27, 31, 40). 
The mutagenesis of the abh promoter further reinforces our finding that the stretch of Ts 
is crucial for activity dependent on σV, since mutating the -28 T on Pabh reduces activity in this 
background just as with the other three promoters tested (Figure 3.6).  Interestingly, for the abh 
promoter, mutating the -28 T does not increase, but reduces, activity in the σM induced 
background, in contrast with what was observed for the other three promoters. The reasoning for 
this effect is still unclear, however it is possible that in the regulation of activity of this promoter  
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Figure 3.5. β-galactosidase activity driven from the PpbpX  promoter and its mutant variant. Data 
corresponds to the induced (+ xylose) β-galactosidase liquid assays. The activity of the wild-type 
(TTTTT) promoter was been set to 100% and the mutant variant activities are expressed as the % 
of wild-type. Experiments were performed at least three times in duplicates; error bars depict the 
standard error. 
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Figure 3.6. β-galactosidase activity driven from the Pabh promoter and its mutant variants. Data 
corresponds to the induced (+ xylose) β-galactosidase liquid assays. The activity of the wild-type 
(TTTTT) promoter was been set to 100% and the mutant variant activities are expressed as the % 
of wild-type. Experiments were performed at least three times in duplicates; error bars depict the 
standard error. 
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the stretch of Ts could also be important for σM recognition. Furthermore, even though the 
activity of the mutated Pabh is decreased for all three σ factors tested, the activity of this promoter 
is not as affected in the wild-type background, suggesting a combination of activities of σM, σX 
and σV or possibly other factors present in the wild-type strain are driving the activity from this 
promoter. Even though it had been reported that expression of abh was in part dependent on σW 
(31), under the conditions tested, we did not observe any Pabh promoter activity in the σ
W
 induced 
background (data not shown). The reasoning for this discrepancy is unclear, but could be due to 
the different strains and reporter fusions used. 
 
3.3.2 In vivo analysis – Stretch of Ts added 
To complement our analysis, we tested a fifth promoter, PmurG, which lacks a stretch of Ts and its 
transcription is dependent on σM only (Table 3.1). This promoter is inside the open reading frame 
of murG, the first gene in the essential peptidoglycan synthesis and division operon murGmurB 
divIBylxXW sbp (9). To this promoter we added a -30/-26 stretch of Ts to replace the CCGAG 
sequence in this position (Table 3.1) and tested for its activity in the ECF σ factor inducible 
strains (Figure 3.7). To our surprise, adding a stretch of Ts to this promoter increased its basal 
activity in the wild-type background, possibly suggesting that it can now be recognized better by 
some of the ECF σ factors. In fact, the activity of this promoter driven by σV has been increased 
10-fold (Table 3.2), further confirming out hypothesis that the stretch of Ts is crucial for σV 
recognition.  
Even though mutating the stretch of Ts seemed to, in some cases, decrease activity under 
σX induction, for PmurG, adding a stretch of Ts does not help the recognition of this promoter by 
this σ factor. Furthermore, the activity of murG dependent on σM was also increased  
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Figure 3.7. β-galactosidase activity driven from the PmurG promoter and its mutant variant. Data 
corresponds to the induced (+ xylose) β-galactosidase liquid assays. Experiments were 
performed at least three times in duplicates; error bars depict the standard error. 
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Table 3.2. β-galactosidase activity driven from the PmurG promoter and its mutant variant. 
 Miller Units 
(AVE) 
STE Foldchange 
(TTTTT/WT) 
168 WT 4.95 0.26 6.02 
168 TTTTT 29.79 0.41 
 Δ7 WT 0.34 0.09 1.72 
Δ7 TTTTT 0.58 0.15 
 Δ7SigM WT 4.45 0.19 2.14 
Δ7SigM TTTTT 9.52 0.38 
 Δ7SigV WT 0.40 0.04 9.73 
Δ7SigV TTTTT 3.92 0.04 
 Δ7SigX WT 0.32 0.09 2.30 
Δ7SigX TTTTT 0.73 0.13 
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(albeit only 2 fold), suggesting the addition facilitates somehow the recognition by σM as well. 
This fact seems puzzling given the fact that for three of the four promoters tested, mutating the -
28 T, and hence disrupting the stretch of Ts, seemed to increase or not affect activity in the σM 
induced background. Whether the stretch of Ts plays a role in σX or σM specificity remains 
unclear, but it is clear that for some promoters it can affect its recognition. 
 
3.4. Conclusions and further remarks 
Overall, our in vivo data supports our hypothesis that the -30/-26 stretch of Ts constitutes a new 
promoter element that is important for σV recognition and specificity. However, how it affects 
recognition by other σ factors, and if it requires other cis- or trans- acting factors (as many 
overlapping σs do) remains unclear. 
In an attempt to corroborate our in vivo results in vitro, we purified RNAP, σV, and σM to 
test with PCR amplicons of PdltA and its mutant variants in run off in vitro transcription 
experiments (Figure 3.8 A and B). We were able to observe a transcript when σM was present 
and which was decreased after all Ts were mutated. However, we could not compare this with σV 
given that our protein preparation seemed to be inactive. We tried several concentrations of the σ 
factor and three different batches of protein but we could not get σV activity. It is possible that 
the inclusion body protocol is inadequate for σV purification, or that σV requires of additional 
factors for activity. In any case, further experiments will be needed to test this.  
We find it puzzling that a single base change within the stretch of Ts could have such a 
drastic effect in promoter recognition, and although we don’t discard the possibility that base 
specific contact between σ and DNA could occur in this region, we presume that the role of the 
stretch of Ts has more to do with the DNA topology or conformation that this region offers.  
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Figure 3.8 PdltA stretch of Ts in vitro and in silico experiments. A) Run-off in vitro transcription 
studies with PdltA as a template and purified σ
M
 W= TTTTT, 1= AAAAA, 2= TAAAT and 3= 
TTATT. B) Run off in vitro transcription studies with PdltA as a template and purified σ
V
 W= 
TTTTT. C) Model representation of stretch of Ts-induced bending of PdltA compared with PmurG. 
DNA bending prediction was constructed using Model.it. 
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Indeed, our preliminary data modeling the DNA structure of PdltA (with stretch of Ts) and 
comparing it with PmurG (with no stretch of Ts) shows that the dltA promoter possess and overall 
bend that could facilitate sigma interaction (Figure 3.8 C). 
In summary, the stretch of Ts constitutes a novel promoter element that is crucial for σV 
recognition and that has variable effects for the other ECF σ factors of B. subtilis. We foresee 
that the continuation of these studies, with an appropriate biochemical counterpart, will provide 
insight into the role of this novel specificity determinant.  
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3.5. Supplementary information. 
Table S3.1. Strains used in this study. 
Strain Genotype Construction or reference 
 
 
E. coli    
DH5α supE44 ΔlacU169 (φ80 lacZΔM15) hsdR17 Lab strain  
BL21/DE3 BL21 with λ DE3 pLys Lab strain  
HE-12023 BL21 DE3 pLys pVG010 This study  
HE-4600 BL21/DE3 pLys pWE01 (9)  
B. subtilis    
168 trpC2 Lab strain  
BSU2007 168 ΔsigMWXYVZylaC (1)  
HB-12010 BSU2007 amyE::PxylA-sigV (13)  
HB-12020 BSU2007 amyE::PxylA-sigW (13)  
HB-12035 BSU2007 amyE::PxylA-sigM (13)  
HB-12036 BSU2007 amyE::PxylA-sigX (13)  
ZB307A W168 SPβc2βΔ2::Tn917::pBSK10Δ6 (MLSR) Lab strain  
HB-12050 ZB307A with SPβ PdltA(AAAAA)-lacZ pVG016 → ZB307A  
HB-12051 ZB307A with SPβ PdltA(TAAAT)-lacZ pVG017 → ZB307A  
HB-12052 ZB307A with SPβ PdltA(TTATT)-lacZ pVG018 → ZB307A  
HB-12053 ZB307A with SPβ PdltA(WT)-lacZ pVG019 → ZB307A  
HB-12057 168 SPβ PdltA(AAAAA)-lacZ SPβ HB-12050 → 168  
HB-12058 168 SPβ PdltA(TAAAT)-lacZ SPβ HB-12051 → 168  
HB-12059 168 SPβ PdltA(TTATT)-lacZ SPβ HB-12052 → 168  
HB-12060 168 SPβ PdltA(WT)-lacZ SPβ HB-12053 → 168  
HB-12061 Δ7 SPβ PdltA(AAAAA)-lacZ SPβ HB-12050 → BSU2007  
HB-12062 Δ7 SPβ PdltA(TAAAT)-lacZ SPβ HB-12051 → BSU2007  
HB-12063 Δ7 SPβ PdltA(TTATT)-lacZ SPβ HB-12052 → BSU2007  
HB-12064 Δ7 SPβ PdltA(WT)-lacZ SPβ HB-12053 → BSU2007  
HB-12065 Δ7sigV SPβ PdltA(AAAAA)-lacZ SPβ HB-12050 → HB-12010  
HB-12066 Δ7sigV SPβ PdltA(TAAAT)-lacZ SPβ HB-12051 → HB-12010  
HB-12067 Δ7sigV SPβ PdltA(TTATT)-lacZ SPβ HB-12052 → HB-12010  
HB-12068 Δ7sigV SPβ PdltA(WT)-lacZ SPβ HB-12053 → HB-12010  
HB-12069 Δ7sigM SPβ PdltA(AAAAA)-lacZ SPβ HB-12050 → HB-12035  
HB-12070 Δ7sigM SPβ PdltA(TAAAT)-lacZ SPβ HB-12051 → HB-12035  
HB-12071 Δ7sigM SPβ PdltA(TTATT)-lacZ SPβ HB-12052 → HB-12035  
HB-12072 Δ7sigM SPβ PdltA(WT)-lacZ SPβ HB-12053 → HB-12035  
HB-12073 Δ7sigWSPβ PdltA(AAAAA)-lacZ SPβ HB-12050 → HB-12020  
HB-12074 Δ7sigW SPβ PdltA(TAAAT)-lacZ SPβ HB-12051 → HB-12020  
HB-12075 Δ7sigW SPβ PdltA(TTATT)-lacZ SPβ HB-12052 → HB-12020  
HB-12076 Δ7sigW SPβ PdltA(WT)-lacZ SPβ HB-12053 → HB-12020  
97 
 
Table S3.1. (continued) 
HB-12077 Δ7sigX SPβ PdltA(AAAAA)-lacZ SPβ HB-12050 → HB-12036  
HB-12078 Δ7sigX SPβ PdltA(TAAAT)-lacZ SPβ HB-12051 → HB-12036  
HB-12079 Δ7sigX SPβ PdltA(TTATT)-lacZ SPβ HB-12052 → HB-12036  
HB-12080 Δ7sigX SPβ PdltA(WT)-lacZ SPβ HB-12053 → HB-12036  
HB-12141 ZB307A with SPβ PbcrC(WT)-lacZ pVG015 → ZB307A  
HB-12142 ZB307A with SPβ PbcrC(AAAA)-lacZ pVG030 → ZB307A  
HB-12143 ZB307A with SPβ PbcrC(TAAA)-lacZ pVG014 → ZB307A  
HB-12144 ZB307A with SPβ PbcrC(TTAT)-lacZ pVG031 → ZB307A  
HB-12145 ZB307A with SPβ empty pJPM122 → ZB307A  
HB-12146 168 with SPβ PbcrC(WT)-lacZ SPβ HB-12141 → 168  
HB-12147 168 with SPβ PbcrC(AAAA)-lacZ SPβ HB-12142 → 168  
HB-12148 168 with SPβ PbcrC(TAAA)-lacZ SPβ HB-12143 → 168  
HB-12149 168 with SPβ PbcrC(TTAT)-lacZ SPβ HB-12144 → 168  
HB-12150 168 with SPβ empty SPβ HB-12145 → 168  
HB-12152 Δ7sigV with SPβ PbcrC(WT)-lacZ SPβ HB-12141 → HB-12010  
HB-12153 Δ7sigV with SPβ PbcrC(AAAA)-lacZ SPβ HB-12142 → HB-12010  
HB-12154 Δ7sigV with SPβ PbcrC(TAAA)-lacZ SPβ HB-12143 → HB-12010  
HB-12155 Δ7sigV with SPβ PbcrC(TTAT)-lacZ SPβ HB-12144 → HB-12010  
HB-12156 Δ7sigV with SPβ empty SPβ HB-12145 → HB-12010  
HB-12157 Δ7sigM with SPβ PbcrC(WT)-lacZ SPβ HB-12141 → HB-12035  
HB-12158 Δ7sigM with SPβ PbcrC(AAAA)-lacZ SPβ HB-12142 → HB-12035  
HB-12159 Δ7sigM with SPβ PbcrC(TAAA)-lacZ SPβ HB-12143 → HB-12035  
HB-12160 Δ7sigM with SPβ PbcrC(TTAT)-lacZ SPβ HB-12144 → HB-12035  
HB-12161 Δ7sigM with SPβ empty SPβ HB-12145 → HB-12035  
HB-12162 Δ7sigX with SPβ PbcrC(WT)-lacZ SPβ HB-12141 → HB-12036  
HB-12163 Δ7sigX with SPβ PbcrC(AAAA)-lacZ SPβ HB-12142 → HB-12036  
HB-12164 Δ7sigX with SPβ PbcrC(TAAA)-lacZ SPβ HB-12143 → HB-12036  
HB-12165 Δ7sigX with SPβ PbcrC(TTAT)-lacZ SPβ HB-12144 → HB-12036  
HB-12166 Δ7sigX with SPβ empty SPβ HB-12145 → HB-12036  
HB-12167 Δ7sigW with SPβ PbcrC(WT)-lacZ SPβ HB-12141 → HB-12020  
HB-12168 Δ7sigW with SPβ PbcrC(AAAA)-lacZ SPβ HB-12142 → HB-12020  
HB-12169 Δ7sigW with SPβ PbcrC(TAAA)-lacZ SPβ HB-12143 → HB-12020  
HB-12170 Δ7sigW with SPβ PbcrC(TTAT)-lacZ SPβ HB-12144 → HB-12020  
HB-12171 Δ7sigW with SPβ empty SPβ HB-12145 → HB-12020  
HB-12172 ZB307A with SPβ PpbpX(WT)-lacZ pVG033 → ZB307A  
HB-12173 ZB307A with SPβ PpbpX(AAAAA)-lacZ pVG038 → ZB307A  
HB-12193 ZB307A with SPβ PpbpX(TTATT)-lacZ pVG032 → ZB307A  
HB-12174 168 with SPβ PpbpX(WT)-lacZ SPβ HB-12172 → 168  
HB-12198 168 with SPβ PpbpX(TTATT)-lacZ SPβ HB-12193 → 168  
HB-12176 Δ7sigV with SPβ PpbpX(WT)-lacZ SPβ HB-12172 → HB-12010  
HB-12177 Δ7sigV with SPβ PpbpX(TTATT)-lacZ SPβ HB-12193 → HB-12010  
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Table S3.1. (continued) 
HB-12178 Δ7sigM with SPβ PpbpX(WT)-lacZ SPβ HB-12172 → HB-12035  
HB-12179 Δ7sigM with SPβ PpbpX(TTATT)-lacZ SPβ HB-12193 → HB-12035  
HB-12180 Δ7sigX with SPβ PpbpX(WT)-lacZ SPβ HB-12172 → HB-12036  
HB-12202 Δ7sigX with SPβ PpbpX(TTATT)-lacZ SPβ HB-12193 → HB-12036  
HB-12182 Δ7sigW with SPβ PpbpX(WT)-lacZ SPβ HB-12172 → HB-12020  
HB-12215 Δ7sigW with SPβ PpbpX(TTATT)-lacZ SPβ HB-12193 → HB-12020  
HB-12192 ZB307A with SPβ Pabh(WT)-lacZ pVG037 → ZB307A  
HB-12189 ZB307A with SPβ Pabh(AAAAA)-lacZ pVG034 → ZB307A  
HB-12190 ZB307A with SPβ Pabh(TAAAT)-lacZ pVG035 → ZB307A  
HB-12191 ZB307A with SPβ Pabh(TTATT)-lacZ pVG036 → ZB307A  
HB-12194 168 SPβ Pabh(AAAAA)-lacZ SPβ HB-12189 → 168  
HB-12195 168 SPβ Pabh(TAAAT)-lacZ SPβ HB-12190 → 168  
HB-12196 168 SPβ Pabh(TTATT)-lacZ SPβ HB-12191 → 168  
HB-12197 168 SPβ Pabh(WT)-lacZ SPβ HB-12192 → 168  
HB-12217 Δ7sigV SPβ Pabh(AAAAA)-lacZ SPβ HB-12189 → HB-12010  
HB-12218 Δ7sigV SPβ Pabh(TTATT)-lacZ SPβ HB-12191 → HB-12010  
HB-12216 Δ7sigV SPβ Pabh(WT)-lacZ SPβ HB-12192 → HB-12010  
HB-12210 Δ7sigM SPβ Pabh(AAAAA)-lacZ SPβ HB-12189 → HB-12035  
HB-12211 Δ7sigM SPβ Pabh(TTATT)-lacZ SPβ HB-12191 → HB-12035  
HB-12209 Δ7sigM SPβ Pabh(WT)-lacZ SPβ HB-12192 → HB-12035  
HB-12199 Δ7sigX SPβ Pabh(AAAAA)-lacZ SPβ HB-12189 → HB-12036  
HB-12200 Δ7sigX SPβ Pabh(TTATT)-lacZ SPβ HB-12191 → HB-12036  
HB-12201 Δ7sigX SPβ Pabh(WT)-lacZ SPβ HB-12192 → HB-12036  
HB-12213 Δ7sigW SPβ Pabh(AAAAA)-lacZ SPβ HB-12189 → HB-12020  
HB-12214 Δ7sigW SPβ Pabh(TTATT)-lacZ SPβ HB-12191 → HB-12020  
HB-12212 Δ7sigW SPβ Pabh(WT)-lacZ SPβ HB-12192 → HB-12020  
HB-12204 ZB307A with SPβ PmurG(WT)-lacZ pVG040→ ZB307A  
HB-12205 ZB307A with SPβ PmurG(TTTTT)-lacZ pVG041 → ZB307A  
HB-12207 168 SPβ PmurG(WT)-lacZ SPβ HB-12204 → 168  
HB-12208 168 SPβ PmurG(TTTTT)-lacZ SPβ HB-12205 → 168  
HB-12220 Δ7 SPβ PmurG(WT)-lacZ SPβ HB-12204 → BSU2007  
HB-12221 Δ7 SPβ PmurG(TTTTT)-lacZ SPβ HB-12205 → BSU2007  
HB-12222 Δ7sigM SPβ PmurG(WT)-lacZ SPβ HB-12204 → HB-12035  
HB-12223 Δ7sigM SPβ PmurG(TTTTT)-lacZ SPβ HB-12205 → HB-12035  
HB-12224 Δ7sigV SPβ PmurG(WT)-lacZ SPβ HB-12204 → HB-12010  
HB-12225 Δ7sigV SPβ PmurG(TTTTT)-lacZ SPβ HB-12205 → HB-12010  
HB-12226 Δ7sigX SPβ PmurG(WT)-lacZ SPβ HB-12204 → HB-12036  
HB-12227 Δ7sigX SPβ PmurG(TTTTT)-lacZ SPβ HB-12205 → HB-12036  
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Table S3.2. Plasmids used in this study. 
Plasmid Description Reference 
 
 
pVG010 pET11a sigV 4626/4627 This study  
pVG014 pJPM122 PbcrC (TAAA) 5073/5074 (5073/5078 + 5074/5077) This study  
pVG015 pJPM122 PbcrC (WT) 5073/5074 This study  
pVG016 pJPM122 PdltA (AAAAA) 5081/5083 (5081/5085 + 5083/5084) This study  
pVG017 pJPM122 PdltA (TAAAT) 5081/5083 (5081/5087 + 5083/5086) This study  
pVG018 pJPM122 PdltA (TTATT) 5081/5083 (5081/5089 + 5083/5088) This study  
pVG019 pJPM122 PdltA (WT) 5081/5083 This study  
pVG030 pJPM122 PbcrC (TTAT) 5073/5074 (5073/5076 + 5074/5075) This study  
pVG031 pJPM122 PbcrC (AAAA) 5073/5074 (5073/5080 + 5074/5079) This study  
pVG032 pJPM122 PpbpX (AAAAA) 5603/5604 (5603/5610 + 5609/5604) This study  
pVG033 pJPM122 PpbpX (WT) 5603/5604 This study  
pVG034 pJPM122 Pabh (AAAAA) 5611/5612 (5611/5614 + 5613/5612) This study  
pVG035 pJPM122 Pabh (TAAAT) 5611/5612 (5611/5616 + 5615/5612) This study  
pVG036 pJPM122 Pabh (TTATT) 5611/5612 (5611/5618 + 5617/5612) This study  
pVG037 pJPM122 Pabh (WT) 5611/5612 This study  
pVG038 pJPM122 PpbpX (TTATT) 5603/5604 (5603/5608 + 5607/5604) This study  
pVG040 pJPM122 PmurG (WT) 5644/5645 This study  
pVG041 pJPM122 PmurG(TTTTT) 5644/5645 (5644/5647 + 5646/5645) This study  
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Table S3.3. Primers used in this study. 
Primer Description Sequence 
 
 
4626 sigV pET11a fwd CACCATATGAAGAAAAAACAAACAACAAAAGCGTTG  
4627 sigV pET11a rev ATAGGATCCTCTTATCCATTAAGAAAGAT  
5073 PbcrC_UNI_Fwd CGCAAGCTTCTGAAGCACTTTAATATCGG  
5074 PbcrC_UNI_Rev ATAGGATCCGTGTTCCCAAACAGCCAGAT  
5075 PbcrC.1_Fwd TCTATTTTTATTTGAAACAAAACATGAGTAAGATTAGTCT  
5076 PbcrC.1_Rev AGACTAATCTTACTCATGTTTTGTTTCAAATAAAAATAGA  
5077 PbcrC.2_Fwd TCTATTTTTATTTGAAACTAAACATGAGTAAGATTAGTCT  
5078 PbcrC.2_Rev AGACTAATCTTACTCATGTTTAGTTTCAAATAAAAATAGA  
5079 PbcrC.3_Fwd TCTATTTTTATTTGAAACTTATCATGAGTAAGATTAGTCT  
5080 PbcrC.3_Rev AGACTAATCTTACTCATGATAAGTTTCAAATAAAAATAGA  
5081 PdltA_UNI.1_Fwd CGCAAGCTTCAAAAACATACGCCGATATA  
5083 PdltA_UNI_Rev ATAGGATCCGAACCGGTATTCGCGGTGTG  
5084 PdltA.1_Fwd AAAAATGAAACAAAAAGAGCATCTGATCGT  
5085 PdltA.1_Rev ACGATCAGATGCTCTTTTTGTTTCATTTTT  
5086 PdltA.2_Fwd AAAAATGAAACTAAATGAGCATCTGATCGT  
5087 PdltA.2_Rev ACGATCAGATGCTCATTTAGTTTCATTTTT  
5088 PdltA.3_Fwd AAAAATGAAACTTATTGAGCATCTGATCGT  
5089 PdltA.3_Rev ACGATCAGATGCTCAATAAGTTTCATTTTT  
5603 pbpX-UNI-Fwd AATGATAAGCTTGGCTGAGTGAAAAACTCAGC  
5604 pbpX-UNI-Rev CAGGGATCCTCTTTTATTTAGTTTTCTCCG  
5605 pbpX-mut.1-Fwd ATTGCTTTTTTTGACAACAAAAAAAGGGCTTTATTCGTCTAA  
5606 pbpX-mut.1-Rev TTAGACGAATAAAGCCCTTTTTTTGTTGTCAAAAAAAGCAAT  
5607 pbpX-mut.2-Fwd  ATTGCTTTTTTTGACAACTAAATTAGGGCTTTATTCGTCTAA  
5608 pbpX-mut.2-Rev TTAGACGAATAAAGCCCTAATTTAGTTGTCAAAAAAAGCAAT  
5609 pbpX-mut.3-Fwd ATTGCTTTTTTTGACAACTTATTTAGGGCTTTATTCGTCTAA  
5610 pbpX-mut.3-Rev TTAGACGAATAAAGCCCTAAATAAGTTGTCAAAAAAAGCAAT  
5611 abh-UNI-Fwd TCAAGGAAGCTTGTAACAGAAGTAATAC  
5612 abh-UNI-Rev GCAGGATCCAATGCCCGTCTCAACTC  
5613 abh-mut.1-Fwd TTATAGAAAGCGGGAAACAAAAACAAAGTTTCATTCGTCTA  
5614 abh-mut.1-Rev TAGACGAATGAAACTTTGTTTTTGTTTCCCGCTTTCTATAA  
5615 abh-mut.2-Fwd TTATAGAAAGCGGGAAACTAAATCAAAGTTTCATTCGTCTA  
5616 abh-mut.2-Rev TAGACGAATGAAACTTTGATTTAGTTTCCCGCTTTCTATAA  
5617 abh-mut.3-Fwd TTATAGAAAGCGGGAAACTTATTCAAAGTTTCATTCGTCTA  
5618 abh-mut.3-Rev TAGACGAATGAAACTTTGAATAAGTTTCCCGCTTTCTATAA  
5644 UNI-PmurG-Fwd GCGAAGCTTGGAATTCCGACTATTGTCCACGAAC  
5645 UNI-PmurG-Rev GCGAAGCTTGGAATTCCGACTATTGTCCACGAAC  
5646 PmurG-mut.1-fwd TGTATTTACGGGAAACTTTTTAGCCTCTGAAGTCGTCTC  
5647 PmurG-mut.1-rev GAGACGACTTCAGAGGCTAAAAAGTTTCCCGTAAATACA 
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CHAPTER 4 
 
YPMB AND MOENOMYCIN RESISTANCE IN BACILLUS SUBTILIS 
 
Moenomycin is a phospho-glycolipid antibiotic produced by various strains of Streptomyces. It 
targets the transglycosylation step of cell wall synthesis in Gram-positive bacteria. In B. subtilis, 
moenomycin selectively induces the extracytoplasmic function (ECF) sigma (σ) factor σM 
regulon. σM regulates genes that are involved in cell wall synthesis, division, and cell shape 
determination. A sigM deletion is much more sensitive to moenomycin than any other ECF σ 
mutation. Here we show that, in a mutant background lacking all seven ECF σ factors, induction 
of σM completely restores moenomycin resistance, whereas induction of σW, σX, or σV does not. 
Due to the considerable amount of overlap between the ECF σ factors of B. subtilis, we took a 
genetic strategy to search for the key moenomycin resistance determinant as genes uniquely 
controlled by σM. Furthermore, we looked at the genes that are positively co-regulated with σM 
and found two transcripts in the ypmAB region. We provide preliminary data that suggests that 
YpmB is a component of the cell wall biosynthesis complex and that it is possibly involved in 
the coordination steps of peptidoglycan synthesis between division and elongation. We have 
found that ypmB mutants are (in addition to moenomycin resistant) morphologically altered, 
sensitive to β-lactams, and unable to grow on defined media. This latter phenotype provided a 
selection for suppressors, some of which also restore the other ΔypmB phenotypes. Intriguingly, 
many suppressors also have aberrant cell morphology, suggestive of cell wall synthesis defects. 
These suppressor strains were targeted for whole-genome re-sequencing, revealing several cell 
envelope- related pathways were affected. Overall, our data suggests that, although possibly not 
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directly involved in moenomycin resistance in B. subtilis, ypmB may play an important role in 
cell wall synthesis. 
 
4.1 Introduction 
The bacterial cell wall is a complex three-dimensional structure that protects the cell from its 
environment while ensuring its shape (26). The synthesis of its main component, peptidoglycan 
(PG), as well as its breakdown and assembly, are crucial processes during cell growth and 
division, and as such require high level coordination of multi-protein complexes (9). Rod-shaped 
bacteria, like B. subtilis, alternate their machineries between division and elongation in a process 
that is spatially and temporally regulated. Several lines of evidence suggest that the actin like 
protein, MreB, plays a central role in this regulation (47). Furthermore, the synthesis and 
maturation of PG is scaffolded on MreB during cell elongation, and coupled with the tubulin-like 
protein FtsZ at mid-cell during division. 
Although seemingly crucial for survival, cell size control is still a poorly understood 
aspect of the cell cycle (45). However, it has been shown that during rapid growth in rich media, 
B. subtilis cells are approximately twice the length of cells grown in nutrient poor conditions 
(36). Additionally, growth-rate dependent increases in cell size have been shown to be correlated 
with increases in DNA content generated by multifork replication (37). It is now believed that 
increasing cell size during rapid growth may be a means of ensuring that division is coordinated 
with segregation of the fully replicated chromosome. 
Moenomycin is a glycolipid antibiotic that inhibits an important step in cell wall 
synthesis, transglycosylation (32). Transglycosylation is performed by high molecular weight 
penicillin binding proteins (HMW PBP) which not only carry out this step, but also 
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transpeptidation. Moenomycin mimics lipid IV, the substrate of transglycosylation, therefore 
inhibiting the activity of transglycosylases (41). Mechanisms of resistance to moenomycin have 
not been described yet. 
 The genome of B. subtilis encodes 7 ECF σ factors, σM, σX, σW, σV, σY, σZ and σYlaC. Of 
these, the physiological roles of σM, σW, σX, and more recently σV, have been well characterized, 
and their target regulons have been defined (10, 12, 18, 19). Both expression and activity of these 
ECF σ factors are often stimulated by cell wall-active antibiotics. 
Here we show that resistance to moenomycin depends critically on σM, and attempt to 
determine the σM-dependent genes responsible for resistance. During our studies, we encountered 
ypmB, although not directly regulated by σM, seems to play an important role in cell wall 
synthesis and possibly interacts with several known σM-regulated cell wall synthesis 
components.  
 
4.2 Materials and methods 
4.2.1 Strain construction and growth conditions 
All B. subtilis strains were constructed in the 168 background (Table 4.1). Unless otherwise 
stated bacteria were grown in liquid Luria-Bertani (LB) medium at 37°C with vigorous shaking 
or on solid LB medium containing 1.5% Bactoagar (Difco). All cloning was done in E. coli 
DH5α using ampicillin (AMP, 100 μg/ml) for selection. Chromosomal DNA and plasmid DNA 
transformations were performed as previously reported (16). The following antibiotics were used 
for selection at their respective final concentrations: spectinomycin (SPC; 100 μg/mL), 
chloramphenicol (CAT, 10 μg/mL), macrolide-lincosoamide-streptogramin B (MLS; contains 1 
μg/ml erythromycin and 25 μg/ml lincomycin), and kanamycin (KAN; 10 μg/ml).  
104 
 
 
Table 4.1. Strains, plasmids and primers used in this study. 
Strain, 
plasmid or 
primer 
Genotype of 
description 
Reference or sequence 
B. subtilis 
 
 
 
168 trpC2 Lab strain 
BSU2007 168 ΔsigMWXYVZylaC (3) 
HB-12259 168 ypmB::mls LFH-PCR → 168 
HB-12279 168 ypmA::mls LFH-PCR → 168 
HB-12280 168 ypmAB::mls LFH-PCR → 168 
HB-12261 168 Pm1-lacZ pVG046 → 168 
HB-12282 168 Pm2-lacZ pVG048 → 168 
HB-12286 ΔypmB Pm-lacZ SPβ HB-0069 → HB-12259 
HB-12054 168 Pm-lacZ SPβ HB-0069 → 168 
HB-0069 CU1065 SPβ-Pm-lacZ (6) 
HB-12010 BSU2007 amyE::PxylA-sigV (12) 
HB-12020 BSU2007 amyE::PxylA-sigW (12) 
HB-12035 BSU2007 amyE::PxylA-sigM (12) 
HB-12036 BSU2007 amyE::PxylA-sigX (12) 
HB-12032 168 ponA::kan LFH-PCR → 168 
HB-12033 168 ypbG::kan LFH-PCR → 168 
HB-13210 168 yfnI::spc Anthony Kingston, unpublished 
HB-10353 168 disA::spc (23) 
HB-12289 168 ydaH::spc LFH-PCR → 168 
Plasmids 
 
 
 
pVG046 pDG1663-Pm1(5823/5821) Amp
R
 This work 
pVG047 pPL82-ypmAB(5905/5907) Amp
R
 This work 
pVG048 pDG1663-Pm2(5920/55921) Amp
R
 This work 
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Table 4.1 (continued) 
Primers 
 
 
 
5821 Pm1-BamHI-Rev CGCGGATCCGCTGCAAATGTGTCAGCATGGAACA 
5823 Pm1-EcoRI-Fwd CGCGAATTCGATGAGACAGCTATTCCAGCGAAAC 
5829 ypmB::mls-up-fwd TTCAGCTCTTGGCACAAGGGATTAC 
5830 ypmB::mls-up-rev GAGGGTTGCCAGAGTTAAAGGATCATGCTTGCCGAGACAAGAAGTACTG 
5831 ypmB::mls-do-fwd CGATTATGTCTTTTGCGCAGTCGGCGTGACGTACTTAGACAAAGAAGGGC 
5832 ypmB::mls-do-rev TCATGTTCAAGGCACACTTCACCGA 
5864 ypmAB::mls-up-rev GAGGGTTGCCAGAGTTAAAGGATCCAAGGCCGAACATCAGATTGTCTCT 
5905 ypmAUP-fwd-bglII GAGAGATCTGTGATACTAGTATGGCGTGTCCTGA 
5907 ypmABDO-rev-sphI GAGGCATGCTGTGATTGCCAGTGTGGTTGATGGT 
5908 ypmA::mls-UP-fwd GCCCGTTATATCGAACTGATGGCAA 
5909 ypmA::mls-UP-rev GAGGGTTGCCAGAGTTAAAGGATCCAGTGTACGATTCAATGTGTCCACA 
5910 ypmA::mls-DO-fwd CGATTATGTCTTTTGCGCAGTCGGCAGAGACAATCTGATGTTCGGCCTTG 
5911 ypmA::mls-DO-rev GTGTGGTTGATGGTGTTAATGCGGA 
5920 Pm2-EcoR1-fwd CGCGAATTCATCGAACGCACAGCGGCATCAATAA 
5921 Pm2-BamHI-rev CGCGGATCCTCTCGCCCATGTTGATCAAGTCGAA 
5766 ponA::kan-up-fwd GCACGTTCATTCACTTCCGTCATGA 
5767 ponA::kan-up-rev CCTATCACCTCAAATGGTTCGCTGTGAAGGACTCGATTTGCTGTTCGCT 
5768 ponA::kan-do-fwd 
CGAGCGCCTACGAGGAATTTGTATCGATACGTCGGATGGTGATTCGAACT
C 
5769 ponA::kan-do-rev AAGGTTCCCAAAGAAGATTGGTCCG 
5770 ypbG::mls-up-fwd GAGCCAGTTCAAAATGTGCCGAATC 
5771 ypbG::mls-up-rev GAGGGTTGCCAGAGTTAAAGGATCCGCAACAGTTAGTACACCGGCAATT 
5772 ypbG::mls-do-fwd CGATTATGTCTTTTGCGCAGTCGGCAAAGTGCCTCTTCGTTTAGGTGCTG 
5773 ypbG::mls-do-rev GTATGTGACCCTAGATCTTCAAGGC 
5806 ydaH::spec-up-fwd GTCGAAGTTGCCGGAAAAGCAAAGA 
5807 ydaH::spec-up-rev CGTTACGTTATTAGCGAGCCAGTCGTCGCATAGGCTAAGGTTTCTATCG 
5808 ydaH::spec-do-fwd CAATAAACCCTTGCCCTCGCTACGCCTCTGTCACAATGGTCACATCAAG 
5809 ydaH::spec-do-rev CAGCGTGTATTGCTTGATGATGCCA 
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4.2.2 Generation of mutant strains.  
Long flanking homology PCR (LFH-PCR) was used to generate deletion mutations in which the 
designated coding region was largely replaced by an antibiotic cassette as previously described 
(24, 43). Strain 168 chromosomal DNA was used for PCR amplification of flanking fragments of 
each gene using primers 5829/5830 and 5831/5832 for ypmB, 5908/5909 and 5910/5911 for 
ypmA, and 5908/5909 and 5831/5832 for ypmAB (Table 4.1). 
The PCR products were joined to an antibiotic cassette using joining PCR with outside 
primers. The final LFH product was used to transform 168 with selection for MLS in all three 
cases (1 μg/ml erythromycin and 25 μg/ml lincomycin) to generate strains ypmA::mls, ypmB::mls 
and ypmAB::mls. The same strategy was used to create ponA::kan, ypbG::kan and ydaH::spc but 
selecting with KAN (kanamycin 10 μg/ml) or SPC (spectinomycin 100 μg/mL) respectively, and 
using the primers listed on Table 4.1. 
 
4.2.3 Plasmid construction 
Ectopic expression of ypmB at amyE, under the control of isopropyl-β-D-thiogalactopyranoside 
(IPTG)-inducible promoter Pspac(hy), was attempted using plasmid backbone pPL82 (34). 
However, we were unable to obtain colonies suggesting that overexpression (even to un-induced 
levels due to “leakiness” of the promoter) is detrimental for growth at least in E. coli. Instead, we 
were able to clone ypmAB using primers 5905/5907 to create pVG047. This plasmid was then 
linearized and transformed to 168 and to ΔypmB where it was shown to complement the mutant 
phenotype (data not shown). 
To create HB-12261 (PM1–lacZ), a DNA fragment containing Pm1 was PCR-amplified 
with primers 5823 and 5821 and cloned into pDG1663 (13). The resulting plasmid (pVG046) 
107 
 
was linearized by digestion with ScaI and integrated into the thrC locus. To create HB12282 
(PM2–lacZ), the same protocol was used except that the DNA fragment was synthesized using 
primers 5920 and 5921 and the resulting plasmid was pVG048. 
 
4.2.4 Disk diffusion experiments 
Disk diffusion assays were performed as described previously (24). Briefly, strains were grown 
in LB medium to an optical density at 600 nm (OD600) of 0.4. A 100-μl aliquot of these cultures 
was mixed with 4 ml of 0.7% LB soft agar (kept at 50°C) and directly poured onto LB agar 
plates (containing 15 ml of 1.5% LB agar). After 30 min at room temperature (to allow the soft 
agar to solidify), the plates were dried for 20 min in a laminar airflow hood. Filter paper disks 
containing either 50 µg of cefuroxime (CXM) or cephalosporin C (CEF-C) were placed on top of 
the agar, and the plates were incubated at 37°C overnight. The diameters of the inhibition zones 
(clear zones) were measured.  
 
4.2.5 Bioscreen experiments 
For liquid growth antibiotic susceptibility tests, fresh single colonies were first grown in LB 
broth to an OD600 of 0.4, diluted 1:100 in LB broth, and 200 μl of the diluted culture was 
dispensed in Bioscreen 100-well microtiter plate. Growth was measured spectrophotometrically 
(OD600) using a Bioscreen incubator (Growth Curves USA, Piscataway, NJ) at 37°C with 
vigorous shaking. The absorbance was recorded every 30 minutes for 24 hours. 
 
4.2.6 Light Microscopy 
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For phase contrast microscopy, fresh colonies were grown on LB at 37 °C with shaking until the 
desired OD. 10 μl of cells were then mounted on Poly-L lysine coated microscope slides. 
Microscopy was performed using a Nikon eclipse e600 microscope. Images were acquired using 
an Infinity2 microscope digital camera. 
 
4.2.7 β-galactosidase assays 
For σM-predicted promoter studies, strains carrying promoter–lacZ fusions were grown to an 
OD600 of 0.4 in LB and then treated with 4 different concentrations of vancomycin, a known 
inducer of σM (10) and samples were collected after 30 minutes. β-Galactosidase assays were 
performed as described (27). 
 For σM induction experiments, the wild-type and ypmB mutant carrying a lacZ fusion to 
the autoregulatory sigM promoter were grown on LB without induction, and samples were taken 
at different OD600. The assays were then performed as above. 
 
4.2.8 Microarray analysis 
Both wild-type and the ypmB mutant were grown in LB at 37°C with shaking to an OD600 of 0.4. 
Total RNA was isolated from two biological replicates using a RNeasy minikit following the 
manufacturer’s instructions (Qiagen Sciences, MD). After DNase treatment with Turbo DNA-
free (Ambion), RNA concentrations were quantified using a NanoDrop spectrophotometer 
(NanoDrop Tech. Inc., Wilmington, DE) and kept at -20°C. 20 μg of total RNA was used to 
make cDNA using the SuperScriptTM Plus Indirect cDNA Labeling System (Invitrogen; L1014-
04). cDNA was labeled using Alexa Fluor® labeling and microarray analysis were performed as 
described previously (14). Four microarrays (biological duplicates with a dye-swap) were 
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analyzed. Images were processed and normalized using the GenePix Pro 4.0 software package 
which produces (red and green [R and G]) fluorescence intensity pairs for each gene. Each 
expression value is represented by up to 8 separate measurements (duplicate spots on each of 
four arrays). Mean values and standard deviations were calculated with MS Excel. The 
normalized microarray datasets were filtered to remove those genes that were not expressed at 
levels significantly above background in either condition (sum of mean fluorescence intensity 
<20). In addition, the mean and standard deviation of the fluorescence intensities were computed 
for each gene, and those for which the standard deviation was greater than the mean value were 
ignored. The fold induction values were calculated using the average signal intensities from the 
three arrays in the different conditions.  
 
4.2.9 Suppressor selection 
A total of ten suppressor mutants were isolated from DSM (Difco Sporulation Media) plates (on 
three different days), where the ypmB mutant failed to grow. Each suppressor mutant was re-
streaked onto new DSM plates and checked for the presence of the mls cassette (marker for the 
mutation). Once checked, the suppressor mutants were labeled PU1-PU10 and characterized 
based on the ΔypmB phenotype. 
 
4.2.10 Whole genome sequencing 
Chromosomal DNA was isolated from the ypmB mutant and four of the suppressors grown in LB 
medium to an OD600 of 0.4 by using the Qiagen DNeasy blood and tissue kit. The quantity and 
purity of DNA were determined using a NanoDrop spectrophotometer (NanoDrop Technologies 
Inc., Wilmington, DE), and DNA was sequenced and analyzed by the Cornell University Life 
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Sciences Core Laboratories Center using Illumina DNA sequencing. The sequence data were 
assembled with CLC genomics workbench (CLCBio) using the reference sequence under 
GenBank accession number ABQK00000000 (38). The sequencing coverage averaged >50X for 
each strain. 
 
4.3 Results and discussion 
4.3.1 Moenomycin resistance is conferred by σM in B. subtilis 
We had previously showed that in B. subtilis, moenomycin can induce expression of σM and its 
regulon, and that a sigM mutant was highly resistant to moenomycin (10, 24, 40). Due to the 
rising evidence of overlap in regulation of ECF σ factors, we wanted to test if σM overexpression 
alone was enough to restore wild-type levels of resistance in a strain lacking all seven ECF σ 
factors. 
Minimal Inhibitory Concentration measurements using moenomycin are impractical 
because higher concentrations of this antibiotic lead to an increased length in lag phase but do 
not prevent growth. After 24 h the wild-type strain is able to grow even after addition of 100 
µg/mL of moenomycin, the Δ7ECF strain however, can only grow up to 0.5 µg/mL of this 
antibiotic (Figure 4.1 top). Ectopic overexpression of  σM not only restores wild-type levels of 
resistance, but even decreases the lag phase observed for the higher concentrations, suggesting 
this strain has an increased level of resistance compared to wild-type (Figure 4.1 bottom). 
Interestingly, overexpression of σV, whose regulon overlaps considerably with that of σM, does 
not lead to this increase of resistance, and neither does overexpression of σX or σW (data not 
shown). This suggests that the gene/s responsible for moenomycin resistance in B. subtilis must 
be exclusively σM -regulated.  
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Figure 4.1. σM confers resistance to moenomycin in B. subtilis. Liquid growth assays were 
performed in LB medium using a Bioscreen C growth analyzer. The wild-type (168), Δ7ECF 
(Δ7) (top panel), and the Δ7ECF overexpression strains for sigM (left) and sigV (right) under the 
induced condition, were grown in the presence of increasing concentrations of moenomycin 
(MOE in µg/ml). Overexpressing σM in the Δ7ECF background completely restores resistance to 
MOE whereas overexpressing σV (σX or σW, not shown) does not. 
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4.3.2 σM –exclusively regulated genes and moenomycin resistance 
In an approach to determine which of the genes on the σM regulon are involved in moenomycin 
resistance, we looked at those that are only regulated by σM. Due to the large amount of overlap 
in regulation of ECF σ factors, we subtracted from the known regulon of σM (10) those genes  
that are also present in the regulons of σW (17), σX (5), and σV (12), to produce a σM-exclusive 
gene list (Table 4.2). 
We constructed knockout mutations of most of these genes and tested for moenomycin 
sensitivity using disk diffusion experiments (Figure 4.2). None of the mutations tested showed an 
increased sensitivity to moenomycin as that observed for the sigM mutant or the ΔECF strain. 
Nevertheless, we do not discard the possibility that these genes are involved in moenomycin 
resistance, especially those with very interesting characteristics.  
For example, ponA encodes for a penicillin binding protein (pbp1A) involved in 
peptidoglycan synthesis (33), however, under the conditions tested, a ponA mutation showed no 
sensitivity phenotype. It is important to note that on these disk diffusion experiments, there is no 
zone of inhibition observed for the wild-type strain (the lawn grows all the way to the edges of 
the disk which is 7mm in diameter) therefore, small increases in resistance cannot be observed in 
this experiment. 
DisA is one of three paralogous diadenylate cyclases required for the production of c-di-
AMP, an essential signal molecule required for cell wall homeostasis (23), however a mutation 
on this gene showed no sensitivity to moenomycin phenotype on bioscreen experiments (data not 
shown). As with ponA, there may be more than one mutation required to obtain a phenotype. 
The only σM –exclusively regulated gene we did not test was murG. murG is part of an 
essential cell wall synthesis operon, and the σM promoter is within the open reading frame of the  
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Table 4.2. Genes exclusively regulated by σM. 
Gene Annotation 
ypbG Putative phosphoesterase. 
(recU)ponA Promoter internal to recU (double strand break repair); ponA: pbp 1A 
ydaH Putative integral inner membrane protein 
yfnI (ltaAS) lipoteichoic acid synthase 
(sms)disAyacLM 
Promoter internal to sms (radA: DNA repair). disA: diadenylate 
cyclase. c-di-AMP 
(murG)murB 
divIBylxXW sbp 
Promoter internal to murG (essential). Peptidoglycan synthesis and 
cell division operon. 
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Figure 4.2. Genes exclusively regulated by σM and moenomycin resistance. Disk diffusion 
experiments performed with the wildtype (168), the Δ7ECF (Δ7), the sigM mutant (ΔsigM) and 
several σM-exclusively regulated genes mutations in the presence of 50 µg of moenomycin 
(MOE). None of the genes tested seemed to be directly or individually involved in moenomycin 
resistance.  
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gene. Therefore, the optimal strategy for functional characterization requires a promoter 
modification in which the M-dependent promoter (PM) is inactivated by a point mutation (as 
done for a PW in (21)). There are many other internal 
M
-dependent promoters, and these will be 
studied as part of a different project with the overall goal of understanding how the M regulon 
contributes to cell wall homeostasis and antibiotic resistance. 
 It is possible that several of these genes are involved in moenomycin resistance and that 
single or double mutations will not lead to a phenotype. A more thorough genetic analysis of 
multiple combined mutations would be ideal to test this. 
4.3.3 σM – positively co-regulated genes and ypmB 
In a second approach to find the M-regulated genes responsible for moenomycin resistance, we 
looked at those positively co-regulated under different conditions of induction of M. The 
transcriptome of B. subtilis has been studied exhaustively, and more recently, a thorough study 
of its transcriptomic response to a wide range of environmental and nutritional conditions that it 
might encounter in nature has been performed (30).  
 Most of the genes that appear to be co-regulated with M had been already reported in the 
several M regulon studies; however, we found a new region that appears to be M-regulated as 
well. There are two transcripts in the ypmAB region of the chromosome that are shown to be up-
regulated with M induction. This region had not come up in our regulon studies; however, it was 
not completely unfamiliar to us. 
 YpmA is a small (56 aminoacids) hypothetical protein conserved in Bacilli, however not 
much is known about its structure or function. YpmB is a 161 aminoacid hypothetical protein 
also conserved in Bacilli. The protein structure of YpmB has been resolved and it shows a single 
transmembrane domain suggesting this protein is anchored to the cytoplasmic membrane of B. 
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subtilis (31). Additionally, sequence homology shows that YpmB has a PepSY domain similar to 
that of M4 family of metallopeptidases. For M4 peptidases, the PepSY domain has been shown 
to have a inhibitory role, which is released after cleavage (48). Whether YpmB serves a similar 
role in B. subtilis remains to be tested.  
 Even though the roles of ypmA and ypmB remain unknown, they have appeared in a few 
studies of relevance to this dissertation. ypmB was found to be one of the most frequent 
insertions in a Tn7 screen for insertions that increase resistance to moenomycin, with a second 
insertion in dinG, the gene directly upstream of ypmAB (15). Furthermore, YpmB has been 
shown to copurify with MreB, albeit together with 98 more proteins, suggesting a possible role 
in peptidoglycan biosynthesis (20). Together, this suggests that YpmB could have an important 
role in cell wall synthesis and could help us understand the role M plays in moenomycin 
resistance. 
 
4.3.2 A ypmB mutant is highly resistant to moenomycin and has pleiotropic phenotypes 
We first constructed a ypmB knockout mutation to corroborate the moenomycin resistant 
phenotype. The ypmB mutant showed an increased resistant phenotype compared to the wild-
type strain (Figure 4.3A). Interestingly, a ypmA mutant and a ypmAB double mutant are also 
resistant to moenomycin (data not shown), however when combined with a sigM mutation, the 
moenomycin sensitivity phenotype prevails (Figure S4.1). This reinforces that the key 
moenomycin resistance determinants are σM dependent. 
Apart from its moenomycin phenotype we also noticed a slight lag phase in growth (~2h) 
characterized with morphologically altered cells with increased length and bending compared to  
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Figure 4.3. Characterization of the ypmB mutant. A) Liquid growth assays were performed in 
LB medium using a Bioscreen C growth analyzer. The wildtype (168) and the ypmB mutant 
(ΔypmB) were grown in the presence of increasing concentrations of moenomycin (MOE in 
µg/ml). The ypmB mutant shows a highly increased resistant phenotype. Data shown is 
representative of experiments produced in duplicates and done at least three times. B) Phase 
contrast microscopy images of the wildtype (168) and the ypmB mutant (ΔypmB) grown on LB at 
OD600 below 0.1. The ypmB mutant shows a higher percentage of filaments and longer cells as 
well as bendy cells. C) Disk diffusion experiments performed with the wildtype (168) and the 
ypmB mutant (ΔypmB) in the presence of 50 µg of cefuroxime (CXM) or cephalosporin-C (CEF-
C). The ypmB mutant shows increased resistance to both antibiotics. 
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wild-type (Figure 4.3B), which resembles those of cells with altered peptidoglycan synthesis 
pathways (25, 29).  
We tested the ypmB mutant for resistance to several cell wall-acting stresses like different 
antibiotics and detergents. We found the ypmB mutant to be more sensitive to the β-lactam 
antibiotics cefuroxime and cephalosporin-C (Figure 4.3C). The fact that the ypmB mutant is 
affected in such a range of phenotypes suggests that it could have an important role in cell wall 
synthesis. 
 
4.3.3 Regulation of ypmB expression 
We next sought to investigate how ypmB expression is regulated. The ypmAB region of the 
chromosome seems to be under tightly regulated control as it appears to have at least six 
different predicted promoters (30), two of which could be σM regulated according to consensus 
searches. The two proposed σM promoters point in opposing directions, one promoter being 
within dinG (labeled PM1) and the one antisense to ypmB (labeled PM2) (Figure 4.4 Top). 
We fused these two promoters to the reporter gene lacZ and tested for β-galactosidase 
activity driven from them under inducing conditions of σM in both the wild-type and a sigM 
mutant strain. PM1 seems to be active under normal growth conditions and its activity is 
increased under induction conditions for σM. Additionally, the activity of this promoter is 
completely abolished in the sigM mutant, suggesting that it is indeed a σM-dependent promoter 
(Figure 4.4 bottom). PM2 showed no activity under any of the conditions tested (data not shown). 
Interestingly, the transcript that is up-regulated under σM-inducing conditions is that of ypmA, not 
ypmB (30) possibly due to activity of PM1. Interestingly, when we tried to overexpress ypmB for 
complementation of our mutation it failed due to toxicity in E. coli, however we were able to  
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Figure 4.4. Regulation of expression of ypmB. Illustration of the ypmAB region and the two 
predicted σM-regulated promoters in it (Top). β-galactosidase activity of PM1 in both the 
wildtype (168) and a sigM mutant (ΔsigM) background under induction of σM with increasing 
concentrations of vancomycin (VAN). 
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overexpress ypmAB together, suggesting a possible negative role of ypmA over ypmB (data not 
shown). Whether ypmA and ypmB are co-transcribed, or if YpmA somehow inhibits YpmB 
activity remains to be further tested.  
 
4.3.4 The ypmB mutant transcriptome is characterized by the induction of a cell envelope stress 
response driven by σM  
To further characterize the ypmB mutant and to gain insight into the different phenotypes it 
exhibits, we used DNA microarray hybridization to monitor transcriptional changes during 
normal growth (OD600 0.4) compared to wild-type. Analysis of the resulting transcriptomic 
response of the ypmB mutant revealed the up-regulation of ~20 genes including many known cell 
wall synthesis components (Table 4.3).  
We also observed induction (2 fold) of ECF σ factors σM and σX, which explains the 
resulting up-regulation of their known regulons. The up-regulation of σM in the ypmB mutant 
might also explain the moenomycin resistance phenotype, since we have shown that over-
expression of σM can restore resistance to this antibiotic even in the absence of all other ECF σ 
factors. 
 In addition to the genes up-regulated, there is a large list of genes down-regulated in the 
ypmB mutant (Table S4.1). The list is largely composed of genes from the Fnr, Fur and Spo0A 
regulons, and the reasoning for this phenomenon still remains to be elucidated. However, within 
this list an interesting one came to our attention, yoeB. YoeB is a cell wall-associated protein that 
protects B. subtilis from autolysis (35), its down-regulation could be due the disruption of cell 
wall synthesis in the ypmB mutant. 
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Table 4.3. Genes up-regulated (foldchange ΔypmB/WT > 3) in the ypmB mutant. 
Genes Foldchange Regulator Annotation Reference 
 
 
yraE 13 G conserved hypothetical protein (44)  
pbpX 6 X(WV) penicillin-binding endopeptidase X (5, 12)  
dctP 6  C4-dicarboxylate transport protein   
manR 4.5  regulation of the mannose operon    
bglH 4.4 A aryl-phospho-beta-d-glucosidase (2)  
mreB 3.6 M cell-shape determining protein (10)  
maf/radC 3.5/3 M putative septum formation DNA-binding protein and putative DNA repair protein (10)  
rnpA 3.4  protein component of ribonuclease P (RNase P) (substrate specificity)   
tagE 3.3 A wall teichoic acid glycosyltransferase (1)  
rluD 3.2  pseudouridylate synthase   
swrC 3.2  transporter involved in surfactin self-resistance   
gntK 3.2 A gluconate kinase (11)  
motP 3.1  putative flagellar motor component (39)  
speA 3.1  arginine decarboxylase   
yrhG 3.1  putative formate/nitrite transporter   
yokF 3  SPbeta phage DNA nuclease, lipoprotein   
ykaA 3 Spo0A putative Pit accessory protein (28)  
ypjD 3  nucleotide phosphohydrolase   
V refers to σV, M refers to σM, X refers to σX,  W refers to σW, A refers to σA and G refers to σG. For those where the reference is not listed the function 
annotation is based on BsubCyc (http://bsubcyc.org/)
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 To corroborate sigM induction, we performed β-galactosidase studies with a lacZ fusion 
reporter gene fused to the auto-regulatory PsigM promoter (PM) in the ypmB mutant compared 
with the wild-type (Figure 4.5). We found that indeed PM induction is higher throughout growth 
in the ypmB mutant, consistent with our microarray results. 
 Overall the transcriptomic data suggest that the ypmB mutant does in fact have alterations 
in its peptidoglycan synthesis pathway, and additionally has a mounted cell wall stress response 
characterized by the induction of σM and σX which may explain some of the antibiotic resistance 
phenotypes. 
 
4.3.5 The ypmB mutant is unable to grow on defined media but readily generates suppressor 
mutants that restore growth 
As mentioned earlier, the ypmB mutant exhibits a range of phenotypes possibly involved with 
cell envelope synthesis defects. In addition to these phenotypes, we found that the ypmB mutant 
is unable to growth on DSM as well as other defined media. Interestingly, after 48h of 
incubation, suppressor colonies appear on the plates (Figure 4.6). 
As a tool to look into the role of YpmB in the cell, we collected and characterized ten of 
these suppressor mutants. We first corroborated that they have had their growth ability restored 
and also checked for the presence of the mutation marker. Once ten suppressors were selected, 
they were labeled PU1-10 and characterized based on the ypmB mutant phenotypes. 
 
4.3.6 The ypmB suppressor mutations have pleiotropic phenotypes 
We first characterized the suppressors based on their colony size and growth rate (Figure 4.7). 
Just like the ypmB mutant, most of the suppressors show a normal colony size, except for PU5 
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Figure 4.5. σM expression in the ypmB mutant. β-galactosidase activity of PsigM-lacZ in the wild-
type (168) and ypmB mutant (ΔypmB) backgrounds. Experiment was performed in 3 biological 
replicas and repeated at least three times. Bars represent mean values with error bars indicating 
the standard deviation.  
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Figure 4.6. The ypmB mutant develops suppressor mutations that restore growth. Image of a 
DSM plate with a streak of the wild-type (168) and ypmB mutant (ΔypmB) strains. The arrows 
depict suppressor colonies that arise after 48-72 h of incubation. 
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Figure 4.7. Characterization of the ypmB mutant suppressors. A) Photograph showing the colony 
size of wild-type (168), the ypmB mutant (ΔypmB), and two suppressor mutants (PU5 and PU1) 
grown on LB plates overnight. Both the ypmB mutant and PU1 (as well as the rest of the 
suppressors (not shown)) show a wild-type colony size. However, PU5 shows a reduced colony 
size. Pictures are representative of experiments performed in triplicate on three different days. B) 
Liquid growth experiments performed with the wild-type (168), the ypmB mutant (ΔypmB), and 
the ten suppressors (PU1-10) in LB and OD600 was monitored over the course of seven hours 
using a spectrophotometer 21. 
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which shows a decreased colony size phenotype (4.7A). In a similar way, most of the 
suppressors exhibited the same 2h lag phase observed on the ypmB mutant, except PU2 which 
had no lag phase and grew like wild-type, and PU7 and PU8 which had a longer (~3h) lag phase 
(4.7B). From this data, we can assume that the different suppressors have not restored all of the 
ypmB mutant phenotypes to wild-type, but only its ability to grow in defined media. 
We also tested if the suppressors had restored moenomycin sensitive to wild-type levels 
and were surprised to find that for the most part, it hadn’t (Figure 4.8). In fact, most of the 
suppressors are highly resistant to moenomycin, even more than the ypmB mutant. The only 
suppressor that was sensitive to moenomycin was PU5, which is more sensitive than wild-type as 
well.  
As far as sensitivity to β-lactams, the results were variable (Figure 4.9). For cefuroxime, 
most of the suppressors remained more sensitive than wild-type (although to different levels), 
except for PU4 and PU6 which are now at wild-type level of resistance. In a similar way, most of 
the suppressors are still sensitive to cephalosporin-C, except for PU8 which is now at wild-type 
level, and PU5 which is more resistant.  
Finally, we looked at the cell morphology of the suppressors to see if the defects in 
growth were still observed. Surprisingly, all of the suppressors still showed defects in growth 
(Figure 4.10). Most of the suppressors now had a smaller size cell type (PU2, PU3, PU4, PU6, 
PU8 and PU10), except for PU1, PU7 and PU9 which still showed the longer, bendy cell type 
similar to that of the ypmB mutant, and PU5 which showed an aberrant “curly” morphology. 
The results of the suppressors’ characterization are summarized on Table 4.4. As far as 
we can tell all of the suppressors, except for PU4 and PU6, have different phenotypes and 
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Figure 4.8. Moenomycin resistance of ypmB suppressor mutations. Liquid growth assays were 
performed in LB medium using a Bioscreen C growth analyzer. The wild-type (168), the ypmB 
mutant (ΔypmB), and the ten suppressor mutants (only PU5 and PU6 shown as representatives) 
were grown in the presence of increasing concentrations of moenomycin (MOE in µg/ml). The 
curves shown are representative of experiments performed in duplicates and at least three times. 
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Figure 4.9. The ypmB mutant suppressors have variable resistance phenotypes to β-lactam 
antibiotics. Zone of inhibition experiments were used to quantify β-lactam sensitivity in B. 
subtilis wild-type (168), the ypmB mutant (ΔypmB) and the ten suppressors (PU1-10). Strains 
were grown to an OD600 of 0.4 and an inoculum of this culture was used to make a lawn of cells 
on 0.75% LB agar. Disks containing 50 µg of cefuroxime (CXM) or cephalosporin C (CEF-C) 
were placed on top of the lawn and the inhibition of growth was measured after incubation at 
37°C for 16 h. Each bar represents the average zone of inhibition of a least three assays 
performed with three biological replicas of each strain. The zone of inhibition is expressed as the 
total diameter (± standard error) of the clear zone. 
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Figure 4.10. The ypmB suppressor mutants show defects in growth. Phase contrast microscopy 
images of the wild-type (168), the ypmB mutant (ΔypmB) and two representative suppressors 
(PU4 and PU5) grown on LB at OD600 below 0.1. 
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Table 4.4. Characterization of the ypmB mutant suppressors. 
Strain 
Lag 
Phase 
DSM 
growth 
Colony 
size 
MOE 
resistance 
CXM 
resistance 
CEF-C 
resistance 
Cell 
morphology 
PU1 ΔypmB + wt R Extra S Extra S ΔypmB 
PU2 wt + wt R S Extra S small 
PU3 ΔypmB + wt Extra R S Extra S small 
PU4 ΔypmB + wt Extra R R S small 
PU5 ΔypmB + small Extra R S Extra R curly 
PU6 ΔypmB + wt S R S small 
PU7 worse + wt Extra R S S ΔypmB 
PU8 worse + wt R S R small 
PU9 ΔypmB + wt Extra R S S ΔypmB 
PU10 ΔypmB + wt R S S small 
ΔypmB ΔypmB - wt R S S ΔypmB 
R: more resistant than 168. S: more sensitive than 168. MOE: moenomycin. CXM: cefuroxime. CEF-C: 
cephalosporin-C. ΔypmB: phenotype similar to that of the ypmB mutant. 
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therefore must have different sets of mutations that arose to compensate for the growth defect of 
the ypmB mutant (i.e. they are not siblings). 
Interestingly, most of the suppressor mutations have a reduced cell size. It has been well 
documented that during rapid growth in rich media, B. subtilis cells are approximately twice the 
length of cells grown in nutrient poor conditions (36), and that increasing cell size during rapid 
growth may be a means of ensuring that division is coordinated with segregation of the fully 
replicated chromosome (45). It seems plausible to think that the ypmB mutant somehow has the 
coordination between division and elongation affected, giving rise to longer cells, which fail to 
grow in limited nutrient conditions. The reversion to a smaller cell phenotype could show 
compensation for this phenomenon. 
Although analysis is still preliminary, we have re-sequenced the genomes of four of these 
suppressors, and the data produced seems very encouraging (Table S4.2). However, more 
analysis and more experiments are needed before stronger conclusions can be drawn. Out of the 
four suppressors re-sequenced, we were able to identify multiple single nucleotide 
polymorphisms (SNPs) in all but one. 
The genome sequence of PU2 revealed a G → T SNP in gtaB that if translated would 
change the asparagine in position 133 to a tyrosine. GtaB is an UTP-glucose-1-phosphate 
uridylyltransferase, involved in glucolipid biosynthesis and which functions as a metabolic 
sensor to coordinate cell size with growth rate in B. subtilis (42). It has been previously shown 
that mutations in gtaB result in reduced cell size, and that it can suppress blocks in cell division 
(as those observed with overexpression of MinCD) (45) .  
As for the other suppressors they all show very interesting SNPs when compared to the 
ΔypmB parental strain. For example, PU10 has, amongst other ones, a silent mutation at the start 
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of walK, part of the two-component system controls peptidoglycan metabolism in exponentially 
growing cells (4); and one that changes a proline to leucine in position 240 of RpoC. Mutations 
in RpoC can often lead to variable phenotypes such as antibiotic resistance or optimal growth in 
minimal media (8, 22).  
One of the suppressors, PU5, has a SNP in ytkD which has been shown to increase the 
spontaneous mutation frequency of growing cells (7); this might explain why there is over 
twenty SNPs on that strain, including a C → T SNP in ftsH which would change threonine 327 
to isoleucine in FtsH, a metalloprotease that accumulates in the midcell septum of dividing cells 
(46). Mutations in ftsH are known to cause defects in growth, characterized by the up-regulation 
of the σW regulon and more specifically pbpE (PBP4) (49). 
A few other suppressor strains are currently being re-sequenced and once the mutations 
are confirmed and reconstructed we will be able to draw a conclusion from each suppressor. 
Nevertheless, it seems that mutations in cell envelope-related pathways are the common theme 
found in these strains which would indicate an important role for YpmB. 
 
4.4 Conclusions and future directions 
Moenomycin is a mimic of the transition state for peptidoglycan transglycosylation and binds to 
PBPs inhibiting their activity. Resistance depends critically on M: A sigM-null mutant is as 
sensitive to moenomycin as the Δ7ECF mutant, and overexpression of M only completely 
restores, even increases, wild-type levels of resistance.  
The M-dependent genes responsible for resistance to moenomycin remain unknown, and 
further genetic analysis might be needed to single them out. However, we found a previously 
uncharacterized gene, ypmB, which could be indirectly regulated by M through ypmA. We have 
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initiated a genetic analysis of the ypmAB region. It is still unclear whether these two genes are 
transcribed as a unit, but it is apparent that this region is under complex regulation involving at 
least one M-dependent promoter. 
 We have found that the ypmB mutant is highly moenomycin resistant, morphologically 
altered, sensitive to β-lactams, and unable to grow on certain media. This growth defect could be 
restored by spontaneous suppressor mutations, several of which also have aberrant cell 
morphology, suggestive of cell wall synthesis defects, which has been supported in some of them 
by whole genome re-sequencing. 
Although preliminary, our data suggest that YpmB plays an important role in cell wall 
synthesis, and expanding these studies to look at YpmB localization using proteomics and 
fluorescence microscopy, will provide novel insights into YpmB and its postulated role in 
modulating the composition and function of cell wall synthesis complexes.  
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4.5. Supplementary information 
 
 
 
 
 
 
Figure S4.1 Disk diffusion experiments performed with the wild-type (168) and sigM, ypmA, 
ypmB and ypmAB mutations as well as the double mutations. 50 µg of moenomycin (MOE) was 
used. Experiments were performed at least three times an in duplicate.    
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Table S4.1. Genes downregulated (foldchange ΔypmB/WT < 0.2) in the ypmB mutant. 
Gene Foldchange Regulator Gene Foldchange Regulator 
 
 
narH 0.007 fnR dhbE 0.15 fur  
narJ 0.01 fnR sboA 0.15   
narK 0.012 fnR ybaC 0.15   
cydD 0.012 
 
nasB 0.16 fnR  
narI 0.018 fnR albC 0.16 Spo0A-AbrB  
aspB 0.029 
 
licB 0.17   
fnr 0.032 fnR yvqE 0.17   
comER 0.059 
 
ywjC 0.17   
narG 0.073 fnR dhbC 0.17 fur  
lctP 0.075 
 
albF 0.17 Spo0A-AbrB  
arfM 0.076 fnR nasD 0.18 fnR  
ytiB 0.077 
 
ecsA 0.18   
yoeB 0.080 
 
albB 0.18 Spo0A-AbrB  
ccpB 0.089 
 
ybcL 0.18   
levD 0.10 
 
yrhH 0.18   
nasA 0.11 fnR yqgZ 0.18   
yvyD 0.11 
 
ydjC 0.19   
yvkC 0.12 
 
cotJC 0.19   
leuA 0.13 
 
pstS 0.19   
dhbB 0.14 fur leuD 0.19   
albA 0.14 Spo0A-AbrB ldh 0.19   
cydC 0.16 
 
ykgA 0.19   
ykfC 0.15 Spo0A-AbrB     
dhbF 0.15 fur     
fruR 0.15 fruRBA     
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Table S4.2 Single nucleotide polymorphisms found in ypmB mutant suppressors 
Strain Reference position Gene Mutation Aminoacid change 
 
 
PU2 3666025 gtaB G → T Asp133Tyr  
PU5 
15564 yaaC C → G Gln77His  
77963 ftsH C → T Thr327Ile  
114846 cysS A → G Glu466Gly  
127903 rpoC A → G His781Arg  
221457 ybdJ T → A Ile67Asn  
277868 ycbK C → G Ala176Gly  
456589 ycsE C → T    
462512 lipC C → T Arg28Cys  
572052 ydeL G → A Asp222Asn  
627010 gmuA C → T    
1009364 yhcY G → C Ala233Pro  
1026236 mcsB T → C    
1308602 exuT T → C Phe386Ser  
1608788 thiQ T → C    
2470067 dsdA G → A Ala287Val  
3135269 ytkD G → C Ala64Gly  
3631239 yvyD C → T Gly112Ser  
3746948 flhO C → T    
3981152 intergenic comS-srfAC C → T    
3988145 yxkD C → T Ala207Thr  
PU7 
117891 nusG T → C Met1  
153429 truA C → G Gln165Glu  
216806 skfC A → G His468Arg  
446132 intergenic gdh-ycnI A → G 
 
 
492178 mntH C → T Ala83Thr  
793922 yetO C → T Thr414Ile  
3233682 yuxJ T → C Leu348Pro  
3393171 gerAB C → T Pro325Ser  
4006089 yxjA T → C Leu113Ser  
PU10 
126280 rpoC C → T Pro240Leu  
151001 ybxA C → T His187Tyr  
1365812 rplD G → A    
4097044 tcyC A → G    
4130991 yydD C → T Gly450Arg  
4151895 walK A → C    
4173610 dtpT A → G    
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CHAPTER 5 
 
CONCLUSIONS AND FINAL PERSPECTIVES 
 
The cell envelope of bacteria is of pivotal importance for growth and survival, and hence it is 
often the target of antimicrobial compounds. Studying the mechanisms that ensure cell envelope 
maintenance under stressful conditions has great significance for the establishment of new 
pathways to target with antimicrobial therapies — a growing problem in antibiotic development 
— enhancement of industrial practices, and could even offer insight into developmental 
processes such as sporulation and biofilm formation. 
B. subtilis is the best characterized Gram positive bacterium (9). It is a soil and 
rhizosphere-associated microbe, and also a gut commensal in animals. The ease with which it 
grows, and the multiple genetic, physiological, and biochemical techniques available for use with 
this organism, ensures that B. subtilis continues to be an excellent tool for the study of cell 
envelope stress responses (CESRs). Furthermore, analysis of B. subtilis and its associated CESRs 
has provided information relevant to many important pathogens including Staphylococcus, 
Mycobacterium, Clostridium, Listeria, the enterococci and streptococci. 
One of the main components involved in CESRs are extracytoplasmic function (ECF) σ 
factors (5). The genome of B. subtilis encodes for seven ECF σ factors, σM, σW, σX, σY, σV, σZ 
and σYlaC (4). In this dissertation, I have performed an in depth analysis of one of them, σV, 
which had been previously uncharacterized. I have described the regulon of σV, the role that it 
plays in lysozyme resistance, and provided evidence for a novel promoter element important for 
σV recognition. Additionally, I have studied the role that σM plays in moenomycin resistance, and 
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discovered a previously uncharacterized gene, ypmB, that seems to play an important role in cell 
envelope synthesis. Taken together, this dissertation was aimed at taking further steps into the 
understanding of the role that ECF σ factors play in regulating the stress response triggered by 
cell envelope acting antimicrobials.  
In chapter 2 a mutant strain lacking all seven ECF σ factors (1) was used to ectopically 
induce the expression of σV to study the transcriptomic response ensued by the activation of this 
ECF σ factor. The regulon of σV revealed abundant overlap with the regulons of σM, σX and σW. 
Two of the operons regulated by σV, dltABCDE and oatA, proved to be indispensable in 
conferring σV-dependent lysozyme resistance in B. subtilis.  
There are several groups currently working on σV and its regulation (3, 10). So far it has 
been found that the activation of σV involves the activity of RasP, as in activation of σW (11), 
however the site 1 protease involved in cleavage of RsiV, has not been determined.  It would be 
interesting to test whether ClpP, ClpX, and ClpE are also involved in σV activation, since they 
have been shown to modulate the RasP-dependent σW stress response (11).  
Little is known about the nature of the signal of activation. Is it a product of degradation 
what induces the response, or the actual physical disruption of the peptidoglycan. It would be 
interesting to assess whether other peptidoglycan degrading enzymes are able to induce σV. We 
have performed some preliminary studies using the N-acetylmuramidase Mutanolysin, but we 
did not observe any quantifiable induction. We don’t discard however that lytic 
transglycosylases, amidases or endopeptidases could have an effect. Furthermore, the 
continuation of our intra- and inter- species studies could reveal a possible role of σV in 
resistance to other peptidoglycan degradation enzymes found in the soil which would be more 
relevant to the niche where B. subtilis grows. 
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The ECF σ factors of B. subtilis play a major role in the regulation of important processes 
such as the cell envelope stress response and antibiotic resistance, however, the functional 
overlap these proteins display complicates the study of their individual functions (6). From the 
studies derived in chapter 2, it was observed that a stretch of Ts in the spacer region of the 
promoters regulated by σMXWV was highly conserved, and virtually absent from promoters only 
regulated by σMXW. In chapter 3 we show in vivo data that supports that the -30/-26 stretch of Ts 
constitutes a new promoter element that is important for σV recognition and specificity, however, 
how it affects recognition by other σ factors, and if it requires other cis- or trans- acting factors 
(as many overlapping σs do) remains unclear.  
One of the most striking results was obtained when mutating a single base, the -28 T, 
from a T to an A base. We presume that the effect shown is not due to base specific contacts, 
however at the moment, we have no evidence for this. One way we could test this hypothesis 
would be to mutate the T to a G or a C and test to see if the effect is observed when the stretch of 
Ts is disrupted regardless of the base used. 
Furthermore, we would like to know if the role of the stretch of Ts is provided by the 
overall topology of the promoter and its influence in the trajectory or flexibility of the DNA. 
This study could be further improved by experiments testing the overall bending of the 
promoters and the different mutant variants studied. The continuation of these experiments 
should provide a better understanding of the role that the stretch of Ts plays in σ factor 
specificity in B. subtilis and enhance our understanding of their overlap in regulation.  
Finally, in chapter 4 we aimed to make progress into elucidating the mechanism by which 
σM confers moenomycin resistance in B. subtilis. Over time our lab has taken several approaches 
to determine the key determinants of moenomycin resistance in B. subtilis. In a previous study, it 
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was found that even though moenomycin appears to have one cellular target; its resistance can be 
achieved by many mechanisms (2). Using Tn7SX transposon mutagenesis, 95 insertions in 25 
different genes were found to increase resistance to moenomycin, most of them linked to cell 
wall synthesis but no specific mechanisms could be elucidated. In chapter 4 we took a different 
approach: given the amount of overlap in regulation by the ECF σ factors of B. subtilis, 
combined with the fact that over producing σM in the Δ7ECF background is sufficient to restore 
resistance to Moenomycin, we sought to investigate the role of M-exclusively dependent genes 
as moenomycin resistance determinants. Unfortunately, none of the single and double mutations 
tested had an effect in moenomycin resistance, suggesting two or more of these genes could be 
involved in resistance. 
Taking an alternate approach, we searched for genes positively co-regulated with σM 
under a number of different growth conditions (7). Most of the genes found had already been 
reported as part of the σM regulon, however, we found a previously uncharacterized gene, ypmB, 
which could be indirectly regulated by M through ypmA. We have initiated a genetic analysis of 
the ypmAB region. It is still unclear whether these two genes are transcribed as a unit, but it is 
apparent that this region is under complex regulation involving at least one M-dependent 
promoter. There is much more to be explored about ypmAB regulation, we could study their 
transcription using RT-PCR or Northen-blots, and map out their transcriptional start using 5’ 
RACE. 
We have found that ypmB mutants are (in addition to moenomycin resistant) 
morphologically altered, sensitive to β-lactams, and unable to grow on certain media. This 
provided a selection for suppressors, several of which also have aberrant cell morphology, 
suggestive of cell wall synthesis defects. These suppressor strains were targeted for whole-
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genome re-sequencing and will continue to be analyzed. The reconstruction of the mutations will 
provide insight into how the ypmB mutation was suppressed.  
In parallel, we would like to investigate the effects of YpmB deletion and/or 
overproduction on the composition and localization of cell wall biosynthetic component as 
monitored using proteomics and fluorescence microscopy. Not much is known about YpmB, 
however this protein has been crystalized and its structure shows a single transmembrane 
domain, suggesting this is a membrane protein (8). We anticipate that continuing biochemical 
analyses will provide novel insights into YpmB and its postulated role in modulating the 
composition and function of cell wall synthesis complexes. 
Overall, the work presented in this dissertation revealed an important role for ECF σ 
factors in antimicrobial resistance. Since the ECF σ factors of B. subtilis play a crucial role in 
regulating the setup of a defense mechanism in response to such stresses, the study of such 
mechanisms is of pivotal importance. Future work continuing these projects would help us 
understand the complex cell envelope stress response mediated by ECF σ factors, and the key 
components of the cell envelope biogenesis machinery.  
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